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Abstract 
Synthetic biology aims to build biological devices to understand living systems 
and explore new applications. Synthetic gene circuits such as genetic switches, 
oscillators and logic gates are at the core of many synthetic biology applications. 
These gene circuits often include a sensor/regulator protein capable to detect small 
molecules and then transduce them into a regulatory signal to generate measurable 
output. Similar signal transduction networks are also abundant in nature. However, in 
many natural and engineered scenarios, the output also affects the regulator/sensor 
protein.  How such interactions between the regulator/sensor and the output affect 
synthetic gene circuit function has not been investigated. In order to address this 
question, I took advantage of Saccharomyces cerevisiae synthetic gene circuits built 
previously in our laboratory: Negative Regulation (NR), Negative Feedback (NF) and 
Positive Feedback (PF). Previous research had characterized the behavior of these 
gene circuits at various inducer (anhydrotetracycline, ATc) concentrations when they 
controlled the bifunctional Zeocin Resistance gene (ZeoR) fused to the reporter 
yEGFP. In these gene circuits, yGFP::ZeoR was a passive target, which did not 
interact with its upstream transcriptional regulator. In order to study the effect of an 
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active target on gene network dynamics, I replaced yEGFP::ZeoR with PDR5::GFP to 
create three new gene circuits, NRpump, NFpump and PFpump. The PDR5 gene 
produces a multidrug resistance pump that belongs to the ATP-binding cassette 
protein family. Once Pdr5 is expressed, it pumps out various small molecule 
chemicals including the inducer, altering the activity of its upstream transcr iptional 
regulators, and thereby creating a feedback loop. Therefore, these reconfigured gene 
circuits enabled the investigation of the question: how the protein pump alters the 
characteristics of the original NR, NF and PF gene circuits.  
In this dissertation, I show that the dose response behavior of the NRpump, 
NFpump and PFpump gene circuits differs from their non-pump counterparts. 
Studying gene circuits controlling non-functional PDR5 mutants indicated that the 
efflux pumping activity of Pdr5 caused loss of linearity in NFpump compared to NF 
dose-response. However, the dose-response behavior of NRpump and NFpump with 
the PDR5 mutant still differed from the behavior of the original NR and NF gene 
circuits. With the help of stochastic models developed by my collaborator, I 
hypothesized and then proved experimentally that lower expression level of the 
regulator, TetR, in all NRpump and NFpump strains (both with functional and non-
functional Pdr5) compared to NR and NF, should be responsible for the remaining 
dose response differences. Similar to the other pump-controlling gene circuits, the 
PFpump gene circuit had a more sensitive dose-response compared to the original 
PF. Although both gene circuits produced bimodal distributions, the finesses and 
cellular transition rates between the two subpopulations were different.  
Finally, I tested the evolution of non-induced NRpump, NFpump and PFpump 
strains in a fluconazole-containing environment. While PFpump cells maintained 
fluconazole sensitivity, NRpump and NFpump cells started to develop fluconazole 
resistance after 48 hours. Expression of Pdr5 was the cause of resistance. The 
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elevated Pdr5 expression level remained the same after fluconazole removal, 
suggesting mutational breakdown of these gene circuits. However, bimodal 
expression patterns evolved in some NRpump and NFpump cell cultures after 256 
hours in fluconazole environment suggesting that other mutations might have 
occurred besides those causing gene circuits’ breakdown.  
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Chapter 1 Introduction 
 
1.1 Introduction and background 
1.1.1 Synthetic biology  
Synthetic biology is an interdisciplinary subject which combines biology, physics, 
engineering and computer science. It emerged as an independent field marked by the 
development of the genetic toggle switch 1 and genetic oscillator 2 in the year 2000. The field 
has been developing so rapidly that no clear definition is widely accepted for now. The one used 
by the Synthetic Biology Community (www.syntheticbiology.org) is ‘the design of new biological 
parts, devices and systems, and the re-design of existing, natural biological systems for useful 
purposes’. By this definition, synthetic biology creates and modifies existing biological systems. 
In order to do that, synthetic biologists employ a variety of tools in existing subjects, for 
example, concepts and technologies developed in molecular biology, systems biology, 
bioengineering, evolutionary biology and biophysics.  
Although synthetic biology is still a very young subject, the idea of building biological 
parts and systems dates back to the mid-70s in the 20th century: the discovery and utilization of 
restriction enzymes and the subsequent emergence of DNA recombination technology. 
Restriction enzymes were discovered by Werner Arber, Daniel Nathans, and Hamilton O. Smith, 
whose work won the Nobel Prize in Physiology and Medicine in 1978 3-9. This significant 
discovery immediately led scientists to be able to map DNA and manipulate nucleotide 
sequence. The advances in DNA recombination technology in the following years then led to a 
series of breakthrough achievements in science and medicine, for example, the modern 
molecular cloning technology and the production of protein drugs.  Inspired by these technology 
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advancements while being aware of their limitations in complexity, scientists hoped to build 
novel biological systems or even artificial organisms to further advance understanding of biology 
and expanding its application. Synthetic biology emerged to study the engineering of biological 
systems. With the aim to engineer biology, synthetic biologists use four major approaches. The 
most common one is building standardized biological parts, including DNA, RNA and protein 
sequence. A variety of existing biological elements have been used, for example, promoter, 
terminator, activator and repressor sequence on the transcriptional regulation level, and UTR, 
splicing sequence and ribosome binding site (RBS) on the translational level 10-19. Several 
existing inventories for standardized DNA elements are also available online, such as BioBricks, 
which has been used widely internationally. Besides standardizing existing biological parts, 
another widely used approach for synthetic biologists is DNA synthesis. Nowadays with the 
rapid advancement of DNA synthesis technology, we are able to synthetize DNA sequence up 
to 5 kb in length, which has significantly improved the plasmid construction efficiency and 
accuracy. It also allows scientists to design DNA sequence with certain mutations, or special 
sequences that do not exist naturally. The third approach that advanced synthetic biology is 
DNA sequencing technology. Because synthetic biology requires high accuracy, advanced DNA 
sequencing technology works faster, cheaper and with higher accuracy rate that will definitely 
benefit synthetic biology. The last but not least used approach is mathematical modeling. 
Because synthetic biologists use standardized elements to engineer biology, computational 
simulation that is able to predict possible outcomes can provide useful insight on how the 
engineered system will behave, and save time and cost for experimental construction.  
Although synthetic biology appeared as an independent subject only 15 years ago, 
numerous achievements have been made. Biomaterial production is among the biggest one. 
Thanks to synthetic biology technology, greener energy sources such as biofuel for jets and 
vehicles is being produced by microorganisms. Cosmetics and food ingredients, vaccine and 
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pharmaceuticals are also being produced by synthetic biology means in biotech and 
pharmaceutical industries. Besides facilitating drugs production, synthetic biology also 
accelerated the discovery of drug targets and facilitated drug delivery. Synthetic systems built 
with controllable biological elements can assist the discovery of disease mechanisms and 
identification of drug target 20; synthetic gene circuits built to work as oscillators can deliver a 
drug periodically as desired 2, 21. In addition, biosensor design is another active research area in 
synthetic biology, which generated influential applications. A series of biosensors were 
developed for both basic scientific research and industrial applications. For example, synthetic 
de-greening biosensors in plants were used to detect explosive molecules in the air 22; metal 
detection biosensors were able to detect certain chemicals underground and were used in a 
mining startup. More fancy research and applications have been created with synthetic biology 
tools. For example, in May 2010, Craig Venter's group announced that they had been able to 
assemble a complete genome composed of millions of deoxyribonucleic acid base pairs. When 
it was used to replace the original genome in a cell, the cell was able to replicate 23, which was 
the first artificial life built in the laboratory. Scientists also use DNA sequence for information 
storage. George Church’s group encoded one of his books on synthetic biology into DNA 24.   
Behind most of these advanced technologies developed by synthetic biologists are 
synthetic gene circuits. ‘Gene circuit’ is a term borrowed from electronic engineering, and it 
reflects the idea that synthetic biologists are treating gene elements as electronic elements, 
aiming to completely control the outcome signal. Under the influence of this concept, toggle 
switches 1, oscillators 2 and digital logic gates 25 were built as first-generation systems. These 
systems successfully integrated regulatory DNA elements into microbial genomes and were 
able to program the behavior of those microorganisms. By doing so, they also discovered the 
switches, oscillators and logic gates in natural biological systems 26. The exciting news of 
programmable cells and natural regulators attracted a number of scientists to work in this field. 
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Initially, they engineered natural promoter sequences to be inducible in order to utilize natural 
transcription factors such as Gal4, TetR and LacI. While the intracellular level of TetR and LacI 
can be regulated by tetracycline family molecules and IPTG respectively 27, 28, synthetic gene 
circuits based on these systems are subsequently under control of these inducers to a range of 
expression. Later on, more complicated gene circuits involving negative feedback loops and 
positive feedback loops were built, and their behaviors were studied 29. With the growth of 
synthetic biology research, the regulation of gene circuits evolved from the transcriptional level 
to include translational and post-translational level regulation. The clustered regularly 
interspaced short palindromic repeat (CRISPR)/Cas9 system was initially discovered as part of 
a bacterial immune system, but now it is used for gene editing and RNA driven gene 
modification 30.   
Despite numerous advances in the study of gene circuits and gene networks, obstacles 
and challenges exist. Living cells are more complicated than electronics; simply applying the 
concepts from electronic engineering is insufficient to engineer biological systems. With 
mutation and evolution playing a critical role in biology, variability of genetic elements created 
big problems. Besides, although our knowledge and information in biology and medicine 
increased exponentially, the unknown expanded to in a greater degree. Therefore, it is very 
difficult to standardize and modularize elements in biology as experts did in the field of 
electronic engineering. Great effort is still needed in order to overcome these challenges in the 
future.   
 
1.1.2 Gene expression noise 
Gene expression is a stochastic process. The variation generated during the gene 
expression process is called gene expression noise. Genomically identical cells growing in the 
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same environment have different expression levels for a gene of particular interest.  For 
example, considering a population of cells with identical genomes cultured in the same medium, 
any particular gene of interest can express different amounts of RNA from cell to cell and over 
time in a single cell. The reason for this difference is random factors, for example, unpredictable 
thermodynamic movement of transcription factors and promoters in the cell, random partition of 
molecules during cell division, response to unpredictable environmental stimuli, etc. This 
phenomena was first observed in experiment by Novick and Weiner that the production of β-
galactosidase was different in each bacterial cell 31.  A few decades later, another group 
confirmed their discovery and further showed that the difference in terms of β-galactosidase in 
individual cells was enlarged by increased induction level 32. However, the effort to study 
stochasticity of gene expression was not done until 2000 when Elowitz et al designed a 
synthetic gene circuit that produced oscillations, which were triggered by stochastic gene 
expression 2. Two years later, the same group designed two gene circuits that have identical 
promoters, but different reporters. Then these two gene circuits were inserted in the symmetrical 
position on the genome of E.coli. Two observations were obtained; first, the expression of two 
reporters showed the same level across the entire experiment; second, two reporters showed 
different expression level 25. These results led to the discovery of two types of gene expression 
noise, extrinsic noise and intrinsic noise. Intrinsic noise refers to gene specific variation that 
comes from the stochasticity of biochemical reactions in the cell such as transcription and 
translation, and it is specific for the particular gene of interest. Intrinsic noise leads to cell-to-cell 
variation in terms of expression level of a particular gene in a cell population. There are many 
factors that contribute to intrinsic noise such as promoter sequence and structure and location 
on the chromosome 33. Extrinsic noise is caused by global factors that indirectly linked to the 
gene of interest in biochemical reaction processes such as transcription, translation and 
biomolecule degradation. For example, the amount of RNA pol II, ribosome and proteasome 
available in the cells contribute to the extrinsic noise in the expression of target genes. Other 
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factors such as variable molecule partitioning during cell division and asynchronous timings of 
their cell cycle also result in extrinsic noise. Extrinsic noise can be categorized into two types 
based on the origin: pathway specific and global. Pathway specific noise can be caused by the 
availability of specific transcription factors, while global noise usually comes from chromatin 
remodeling or ribosome abundance 33.  Elowitz et al also discovered that promoter strength was 
related to both intrinsic and extrinsic noise 25. Their conclusion was later confirmed by the 
discovery that transcription and translation occurred in bursts in bacteria 34-37.  
After these discoveries in bacteria, research on gene expression noise in eukaryotes 
attracted more attention. Although transcriptional busts have been confirmed as one of the 
sources for gene expression noise in yeast cells, research in budding yeast has discovered that 
gene expression noise in eukaryotes is different from bacteria 38-41. The most important 
difference is chromatin remodeling. In eukaryotic cells, DNA is packed with nucleosome to form 
a compact structure, the chromosome. When transcription begins, chromatin structure switches 
into open and acetylated state from a condensed structure, where transcription is blocked. 
Studies also identified that essential genes tend to cluster together while non-essential gene 
cluster together on the genome, and established the correlation between the location of gene 
clusters and gene expression noise. They found that essential gene expression is much less 
noisy than non-essential genes and this was because of their location on the chromosome 42. 
The location where essential genes cluster showed open chromatin structure, while location 
where non-essential genes cluster had more condensed structure on the genome 43. Locations 
of transcription factors were also found to be influential over gene expression noise 44. 
Additional studies indicated that the gene expression noise in yeast cells is mostly from extrinsic 
origins, which was confirmed by the fact that different genes showed the same noisy expression 
pattern 38, 45-47. Cell size and chromatin remodeling were considered the major contributors 46-48. 
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However, the theoretical studies of extrinsic noise are still lacking because of lack of robust 
mathematical models 49.  
With technical advancement and increasing knowledge of gene expression noise in 
budding yeast, more interest has been attracted to study that in mammalian cells. In the 
beginning, gene expression noise was expected to be much lower in mammalian cells, because 
of their low protein numbers the lower number of molecules, the higher randomness it becomes 
50. However, more and more research has found the opposite. Measurement of mRNA 
expression in single cell observed burst of transcription 51-54, which showed similar pattern as it 
was observed in bacterial cells, but lasting longer and less frequent. Similarly,  protein 
expression was also observed to happen in bursts in mammalian cells, which resulted in cell-
cell variation 43.  
The discovery that essential genes tend to cluster together on chromatin open locations 
suggested that noisy expression of essential genes may have lethal consequences. However, 
the relatively more noisy expression of nonessential genes triggered the idea that noise can be 
beneficial to certain cells or in certain circumstances. One major outcome of noisy gene 
expression is to create diversity of phenotypes. One example is the expression of odorant 
receptors in sensory neurons in mice. Over a thousand odorant receptors have been found in 
different sensory neurons, their expression was random and mutually exclusive 55, 56. Our 
traditional view of stem cell diffraction and development is deterministic. However, stochastic 
gene expression has been shown to play a major role. Researchers found that genomically 
identical individual cells with expression of certain stem cell markers correlate with their further 
fate of differentiation 57. Not only was an advantage of gene expression noise was found in 
mammalian cells, it was also discovered in unicellular organisms. Genes encoding metabolic 
pathways are stochastically switched between on and off states. For example, gene products 
that utilize lactose as energy source in E. coli 58, 59 and the GAL3 gene in yeast 60. Some 
8 
 
attempts have been made to explain the causes of these phenomena. Some researchers 
claimed that stochastic switching between two states maximize the growth rate of cells 
population when environment change frequently 35, 61.  Bacterial cells use expression noise of 
drug resistance gene as a protective strategy against adverse environment 62. When adverse 
environment comes, cells with high expression of drug resistance genes are more likely to 
survive. Another example involves the competence in B. subtilis. Two survival states exist in B. 
subtilis, competence and vegetative states. In competence state, comK expression was 
activated and its expression amplified by a positive feedback loop, while vegetative state 
showed only basal level of comK expression. The two states resulted in bimodal expression of 
comK in a cell population, and they transit between each other 63. In summary, gene expression 
noise is random, and can be both good and bad depending on the situations. To really answer 
these questions, we ought to ask, can noise be regulated? The answer is yes, synthetic 
biologists are already using different regulatory network to regulate gene expression noise.  
 
1.1.3 Synthetic gene circuits for noise control 
Based on the studies to understand and characterize gene expression noise in both 
natural and synthetic systems, researchers also attempted to control noise by building synthetic 
gene circuits. The first attempt was to control a downstream reporter by upstream regulatory 
elements to study its gene expression noise 36, 64, 65. They found that the variation in the 
upstream regulatory parts can affect expression noise in the downstream genes, and the effect 
was heritable. Later on, more research has been done to investigate more complex synthetic 
gene circuits. I am going to talk about the basic gene circuits in the following context. 
 
Auto regulation  
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Auto regulation is the simplest regulatory cascade in the transcriptional level. Basically, it 
needs a transcription factor that binds to its own promoter and regulates its own expression. 
Auto regulation can happen in either self-inhibition or self-activation forms. Research has found 
that the auto regulation on gene circuit was able to reduce noise by decreasing the size of 
transcriptional bursts, which caused the reduction of time to reach steady states 66-70.  Besides, 
auto regulation is also involved in oscillation induction and reduces the metabolic cost by 
reducing mRNA usage 2, 71, 72.  On the contrary, positive auto regulation has been found to 
increase gene expression noise and take longer time to reach steady states 67.  
 
Negative feedback (NF) gene circuit 
Negative feedback gene circuit involves more complex regulatory components. On the 
transcriptional level, usually there is a repressor that represses the transcription of both the 
transcription factor and downstream target gene. It has been found that negative feedback loop 
was able to reduce gene expression noise (for both transcription factor and the downstream 
target gene) and speed up the response time 66, 73, 74. Because only one steady state has been 
demonstrated to exist, any fluctuations deviating from the mean would be pushed back 35, 74-77.  
It was also able to generate linear response to inducer up to saturation 29. By modifying the 
number of repressor binding sites on the target promoter region, the authors were able to 
change the linearity of the dose response curve, which indicated the correlation between 
promoter sequence and the noise expression in synthetic gene circuits 29.  
 
Positive feedback (PF) gene circuit 
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Positive feedback regulatory network is usually composed of a transcription factor that 
regulates a downstream target gene. An activator is able to activate the transcription of both 
itself and its downstream target gene. Positive gene circuits have been found to amplify noise. 
Therefore, a low activator expression is able to activate further expression of it and the target 
gene, which usually led to the two stable steady states, one with maximum level of expression, 
and one with basal level. It has also been found that cells in these two states were able to 
switch between states 1, 77-80. Further studies discovered that the switching rates between the 
two states were different, and the existence of stable bimodal expression states were a result of 
different cellular growth rate memory in the two states 81. Cellular memory refers to the time an 
individual cell staying in one stable steady state 60.  
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A 
 
B 
 
C 
 
D 
 
 
Figure 1.1 Scheme of auto regulation and feedback regulation. 
A. Auto regulation (Inhibitor). B. Auto regulation (Activator). C. Negative feedback regulation. D. 
Positive feedback regulation  
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1.1.4 Tetracycline controlled transcription 
Tetracycline controlled transcription is a system that was developed from the tetracycline 
resistance operon in E.coli 28. The natural operon functions to protect bacterial cells from 
antibiotics such as tetracycline. It is composed of a Tet repressor, TetR, which inhibits the 
transcription of the tetracycline resistance protein, TetA. The TetR binding sites on the promoter 
are called TetO sites. It’s been reported that the binding of tetracycline or its derivatives 
(doxycycline, etc) are able to reduce the affinity between TetR and TetO by 9 orders of 
magnitude, which leads to the release of TetR from the promoter and therefore activation of 
target gene transcription. Researchers started to use this natural system to study the gene of 
interest by placing it under the control of a natural tetracycline resistance promoter. This is 
called the T-REx system. Later on, Tet-on and Tet-off were distinguished; since then, more 
research has been done to modify and improve the system 82-86. Placing the TetO sequence on 
other natural promoters in other bacteria, yeast and mammalian cells revealed that the modified 
Tet systems were able to induce transcription of target gene of interest again as well. Further 
modifications also led to the construction of Tet-On system. This system is composed of an 
activator instead of the repressor in the T-REx system, and the TetO sequence in the promoter 
region. The activator activates the transcription of the target gene in two ways, induced by 
tetracycline or not. Other modification has also been done to increase the activator’s sensitivity 
and specificity to doxycycline, which works better than tetracycline in terms of its lower light 
sensitivity 83. The activator in Tet-on system, tTA, was originally created by fusing TetR with the 
acidic domain of HSV VP16, which is a transcriptional transactivation domain in eukaryotic cells. 
As a result, binding of tetracycline family molecules leads to the release of rTA from the 
promoter and inhibits transcription of target genes. Another activator that has been used widely 
is rtTA, which was modified on the basis of tTA by introducing a few mutations on TetR, which 
transferred the function of transactivator to bind DNA in the presence of inducer. rtTA requires 
binding of tetracycline to activate the transcription of target genes. Recently, a more advanced 
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Tet-on system was created, Tet-Oh 3G, which showed reduced basal expression and higher 
sensitivity to inducers. This new system was constructed by using human optimized codons 84.  
 
1.1.5 ATP-Binding Cassette (ABC) family 
The ATP-binding cassette (ABC) superfamily was first discovered in bacteria 87. Early 
biochemists studying molecules across cell membranes discovered that the transporter in 
charge of the process was also responsible for regulatory and other functions. Researchers 
later discovered that some of the transportation processes were coupled with ATP hydrolysis, 
which led to the identification of a group of closely related proteins in several bacterial species 
88-90. These proteins are both functionally and structurally related, as they are all involved in cell 
division, and substrate transport across the membrane and ATP hydrolysis. Later on, ABC 
family proteins were discovered in eukaryotes, including yeasts and humans, and their 
importance rose significantly after the discovery of their role in multidrug resistance in a variety 
of diseases. Increased expression of ABC family proteins was associated with resistance to 
chemotherapy in cancer and fungal infections, which usually led to the failure of medical 
treatment. Since then ABC family proteins received considerable attention. The structure of 
ABC transporters is highly conserved, including a phosphate binding domain and the consensus 
sequence ‘LSGGQ’. It has been reported that 1% to 3% of the genome in microbes encodes 
ABC transporters 91. 48 ABC transporters have been identified in human so far 92, 93.  
In Saccharomyces cerevisiae, 31 ABC transporters have been discovered, and they 
have been divided into 5 subfamilies based on their phylogenetic features 94.  Among them, the 
Pleiotropic drug resistance (PDR) proteins are mainly responsible for multidrug resistance by 
exporting toxic molecules across cell membrane. There are 9 full sized proteins in the PDR 
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subfamily, PDR5, PDR10, PDR11, PDR12, PDR15, PDR18, SNQ2, AUS1 and YOL075c 95. 
Pdr5 plays the most important role in transporting molecules across cell membrane.  
 
1.1.6 PDR5 
PDR5 gene was discovered in 1990 when Leppert G et al. cloned a DNA fragment that 
was able to confer resistance to cycloheximide and sulfometuron methyl treatment by 
overexpression in yeast cells 96, while mutants with disruptive mutation on PDR5 showed 
hypersensitivity to these drugs. Then PDR5 was identified to be regulated by the transcription 
factor, PDR1 in S. cerevisiae. Four years later, the complete sequence of PDR5 was published 
and then this 160-kDa protein was officially considered as a member of ABC family. Further 
studies by Leonard et al and Kolaczowski et al indicated that the non-functional PDR5 mutant 
led to reduced R6G (a fluorescent dye) and drug efflux, and demonstrated that PDR5 deficient 
cells were more sensitive to anti-cancer drugs 97, 98.   
The Pdr5 protein is composed of two transmembrane domains (TMDs) and two 
cytoplasmic domains (NBDs). TMDs include 12 alpha helices on transmembrane segments 
(TMSs) and several of them associate with each other compromising the substrate binding sites 
99, 100. Site-directed mutagenesis studies revealed that individual TMSs sequences 
predominantly determined substrate specificity. Function and position of several TMSs have 
been identified. TMS 2 locates at the binding pocket of Pdr5, and TMDs10 is on the opposite 
position. TMS1 and TMS7 are responsible for membrane localization of the entire TMDs 101. 
Although effort and progress regarding the structure and function of TMDs have been made, no 
exact structure of TMDs have been discovered so far, Rutledge et al proposed computational 
simulation of Pdr5 structure based on its amino acid sequence 102, 103, which might give insight 
for further study on TMDs structure. NBDs are located at the cytoplasmic side of Pdr5 protein 
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and are mainly responsible for ATP hydrolysis, which provide energy for the conformational 
change on TMDs.  Unlike TMDs, which have rare sequence homology across different ABC 
transporters, NBDs are relatively well conserved. Certain sequences are highly conserved on 
NBDs and play very important functions. These sequences include the Walker A motif, Walker B 
motif and ABC signature. Research discovered that the association between Walker A motif and 
the β- and γ-phosphates of ribonucleotide is essential for ATP hydrolysis 101.       
ABC family proteins have an enormous variety of substrates. Generally, the two trans 
membrane domains (TMDs) are responsible for substrate recognition and binding while the two 
nuclear binding domains (NMDs) provide the energy source and facilitate the conformational 
change 100. The TMDs can switch between two structures, the inward facing substrate binding 
structure, and outward facing substrate release structure 89. It has been discovered that TMDs 
with these two conformations have different affinities towards the substrates, which might 
explain one way efflux pumping function of Pdr5. Based on previous research and discoveries, 
a simple model of substrate efflux pumping has been proposed. The process starts with TMDs 
in the inward facing conformation, while their substrate binding sites are active. Once TMDs 
recognize their substrates and bind to them, NBDs bind to ATP and start to hydrolyze it into 
ADP, which provides the energy for the conformational change on TMDs. Then TMDs change 
from inward facing position to outward facing position, substrates are transferred from the 
cytoplasm to the outer site of cell membrane. Because TMDs’ affinity for the substrates is 
significantly reduced in outward facing conformation, substrates are released to the outside 
environment. Recent research found that this decreased affinity for substrates in outward 
position might be due to the position change of active binding sites on TMDs. After the 
substrates release, TMDs switch back to inward facing conformation, and ADP is converted into 
ATP and released from NBDs. This model explained the efflux pumping function of Pdr5 well, 
but some detailed mechanism are still unclear and the order of steps in the model is in debate. 
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Robert et al discovered that the two NBDs on Pdr5 do not function equivalently. Site directed 
mutation assays indicated that the ATP hydrolysis at NBD2 active sites is important to initiate 
TMD conformational change, while the ATP hydrolysis site at NBD1 is negligible. Higgins & 
Linton proposed that the ATP hydrolysis only occurred after substrates release from TMDs in 
the outward facing conformation. However, 3 years later a contradictory conclusion was made 
by Oldham et al that the cross talk between TMDs and NBDs are essential mechanism to 
prevent ATP hydrolysis and NBDs dimerization without binding to substrates.  
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Figure 1.2 Structure of Pdr5. 
Pdr5 has four domains, two transmembrane domains (TMDs) and two nuclear binding domains 
(NBDs). NBDs were initially associate with ATP, once TMDs bind to the substrates, ATP was 
hydrolyzed into ADP, which then changed the conformation of TMD, and the substrates were 
pumped out.  
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Another intriguing question that has been studied for years was the extremely diverse 
substrates of Pdr5. In order to study this, researchers replied on the experience from studies of 
other ABC family transporters. The Pdr5 homologous protein in human cells, p-glycoprotein was 
discovered in 1971, almost 20 years before the first identification of Pdr5. Its importance drew 
much attention since its involvement was found in resistance to anticancer drugs. Although rare 
similarities had been found on their sequence, their functions and substrate recognition were 
similar, Marcin Kolaczkowski et al discovered that the two proteins share 22 substrates and their 
efflux pumping function were both inhibited by the same inhibitors 104-106. A series of random and 
site directed mutagenesis assays revealed that the transponder inhibitor and some of the 
mutants with impaired efflux pumping function depend on the same structural feature.  Further 
studies using different types of substrates found that Pdr5 might have two or three substrate 
binding sites. However, even though multiple substrate binding sites have been identified, the 
mechanism of selection of various types of substrate is still unclear. In 2003, Golin et al reported 
that Pdr5’s recognition of substrates is site-dependent; the optimum size of Pdr5 substrates is 
around 200 to 225 Angstron 107. In 2007, the same group published another discovery that 
hydrogen bonds formed between TMD and the substrates also contribute to the substrate 
selection 108-110. However, debate in this field is still ongoing. In 2009, R. Ernst proposed the 
kinetic substrate selection model, namely that the substrate selection of Pdr5 was determined 
by the kinetics of transporter-substrates and transporter-nucleotide 111. In the model, the authors 
argued that more substrates being transported out of the cytoplasm did not necessarily equal 
higher substrate affinity. For example, given the same affinities of fast and slow substrate 
kinetics, the one with fast kinetics is transported more efficiently, which resulted in more 
substrates transported out by Pdr5.  
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1.1.7 Biofuels and their production 
Industrialization improved the quality of human lives significantly, but on the other hand, 
it aggravated the environment we all depend on. According to United States Environmental 
Protection Agency, the emission of greenhouse gases has been increasing dramatically since 
1950, when the consumption of fossil fuels was 1/7 of the amount used in 2008, and it along 
accounted for 57% of the total greenhouse gas emission globally. The use of fossil fuels has 
changed our climate irreversibly and caused global warming, it also resulted in the production of 
acid rain, smog and harmful particles in the atmosphere. This adverse effect endangered 
hundreds of living organisms and is threatening our own lives as well. Therefore, the demand 
for clean energy sources now has become stronger than ever. The mainstream alternative 
energy sources are wind, solar, nuclear and bioenergy. Bioenergy refers to the energy sources 
generated from living organisms or organic products.  The huge benefit of bioenergy and the 
leading potential of bio-economy therefore attracted attention from the scientific community. 
Research in the field of biofuel production has been intense and numerous improvements had 
been made. The first generation biofuels were mostly bioethanol, biodiesel and biogas made 
from sugar, starch, vegetable oils or animal fat. They are able to blend with current petroleum 
based fuels, fit the internal combustion engines and distribute through existing infrastructure. 
Therefore, it has been widely used in transportation today 112. However, the first generation 
biofuels also caused concerns. They were produced from food sources, and naturally competed 
with food consumption 113. With a strong will to produce economically advantageous biofuel in 
the scientific community, second generation biofuels appeared. This novel biofuel type 
produced from plant biomass, which mainly refers to the lignocellulosic feedstock. Those 
lingocellulosic materials are abundant and cheap. Most importantly, it is not food source, and on 
the contrary, it is mostly waste and need to be degraded. However, the cost of production of 
second generation biofuel turned to be much higher than fossil fuel. The major obstacle now is 
the biofuel productivity and yield. A number of microorganism hosts have been studied to 
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produce biofuel, such as Escherichia coli, Saccharomyces cerevisiae, Zymomonas mobilis, 
and Clostridium acetobutylicum. These microbes’ metabolic pathways were modified to 
maximize the production of biofuel.  The genome of Escherichia coli was engineered to do both 
plant biomass digestion and hydrocarbon production at the same time 114.  The metabolism of 
fatty acid production were rewired in the DNA level in E. coli to overproduce fatty acyl-CoA, 
which is a general substrate for the production of esters and alcohols 115, 116. Hydrogen 
production pathways were modified in algae and cyanobacteria to enhance photosynthesis and 
sugar storage 117, 118. Non-essential metabolic pathways were also eliminated 119. In order to 
maximize the production of biofuels, scientists not only work on the genome level, even RNA 
and proteins were engineered as scaffolds for metabolic pathway optimization 120. 
Although tremendous effort has been put on the research to improve biofuel production, 
one major challenge still remained. Too many biofuel molecules are toxic to the microbe hosts, 
which will decrease their growth rate and therefore, further biofuel production. Over production 
of biofuel molecules in those microbes cause direct damage to proteins or other large molecules 
that are essential for the cells to maintain growth rate, and therefore cause stress response 121-
124. Other damage that biofuel molecules may cause is cell membrane permeability. Biofuels are 
easily attached to the cell membrane because of the high carbon and fatty acid in both 
complexes, and therefore, unbalance the chemical and electronic gradients across the cell 
membrane. One solution is to select microbe strains that are highly tolerated with high 
intracellular biofuel concentration. The other one is to use efflux pumps to exclude biofuel and 
keep the microbes growing at an optimized rate.   
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1.2 Significance of the study 
Synthetic biology aims to build biological devices for predefined purposes 26, 125-128. One 
important goal for synthetic biologists is to construct synthetic gene circuits 129, 130 that function 
as switches, oscillators, logic gates, precise dimmers, or counters 1, 2, 29, 71, 131-135. Small molecule 
inducers that bind to the protein components of such gene circuits are often used to control their 
function externally. The hope is that by placing specific genes under the control of such 
inducible synthetic gene circuits, users can deliver precise stimuli to cell populations. For 
example, the use of synthetic gene circuits can improve the controlled secretion of drugs or 
biofuel compounds for clinical or industrial purposes 123, 136. Secreting drugs and biofuels 
requires protein pumps that actively move them across the cell membrane. ATP-binding 
cassette (ABC) family multidrug resistance pumps are prime candidates to fulfill this function. 
Highly conserved across bacteria, fungi, and mammals, ABC family pumps cause microbial 
resistance to antibiotic treatment and chemo resistance to tumors by pumping out a wide range 
of compounds into the extracellular medium 137. However, protein pumps controlled by synthetic 
gene networks that respond to inducers can secrete the intracellular inducer and thereby lower 
its concentration (in addition to the molecule species they are intended to secrete). This 
introduces a feedback 138 that may alter the function of synthetic gene networks, and may be 
important to understand if protein pumps are to be used as parts of synthetic gene circuits. Yet, 
the effect of protein pumps on synthetic gene circuit function has not been thoroughly 
investigated.  
The major goal of this dissertation was to study the interaction between a protein pump 
and three gene circuits that regulate it. To answer this question, I modified three previously 
characterized, TetR-based synthetic gene circuits inducible by tetracycline analogs, called the 
negative regulation (NR), negative feedback (NF), and positive feedback (PF) gene circuits. My 
lab members have characterized previous versions of these gene circuits that control a passive 
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target gene (yEGFP::zeoR), which does not affect its upstream transcriptional regulators 29, 81. 
Here, I replaced this passive target gene with the yeast pleiotropic drug resistance pump-
fluorescent reporter fusion gene PDR5::GFP. Once PDR5::GFP is expressed, it pumps out the 
inducer, altering the activity of its upstream transcriptional regulators, and creating a negative 
feedback loop. I showed by experiment how this feedback loop altered the dose-response of the 
original three gene circuits. Moreover, I also identified mechanisms underlying an additional, 
unexpected change from introducing the gene that encoded the protein pump that applied to NR 
and NF gene circuits. Additional changes for PF gene circuit caused by PDR5 was discovered 
as well in terms of growth rate and cellular memory.  
Another question this dissertation addressed was the evolution of gene circuits. One 
goal of synthetic gene circuits was to study regulatory networks that commonly exist in natural 
systems. Study of the evolutionary course of synthetic gene circuits was able to provide clues 
on the evolution and natural selection of natural regulatory networks, such as the positive loops 
in the transcriptional regulation of natural PDR5 gene. Here I evolved these three gene circuits 
controlling PDR5::GFP fused gene in constant fluconazole environment. The results were 
unexpected, and potential evolutionary mechanisms were identified. The results uncovered the 
interaction between PDR5 and its upstream regulatory elements during evolution course in 
fluconazole containing environment.  
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Chapter 2 Materials and methods 
 
2.1 Experiments 
2.1.1 Construction of synthetic gene circuits 
Each synthetic gene circuit we used consisted of two parts originating from separate 
plasmids: a bifunctional reporter and the regulator (Figure 1). We obtained the PDR5::GFP 
fusion by PCR amplification from whole-genome extraction of the GFP-tagged yeast library 139 
and cloned it into the pRS4D1 integrative yeast plasmid, which was used to build the NRpump, 
and NFpump gene circuits 39, 40, chromosomally integrated into the GAL1-GAL10 locus as 
previously described 29, 140. In each NRpump558/312 NFpump558/312 version, a single 
nucleotide mutation was introduced on PDR5 gene before following the same procedure for 
yeast genome integration. In the S558Y mutant, the C was changed to A at position 1673 in the 
PDR5 gene. In the G312A mutant, the G was changed to C at position 935 in the PDR5 gene. 
For the construction of two color gene circuits, TetR gene in the regulator plasmid was replaced 
with TetR::mCherry fusion gene. Other construction procedures were the same.  
Primers used for the construction and verification of gene circuits: 
PDR5::GFP fusion primers: 
PDR5-BamHI-f:               5’-gcgcggatcctattaaaATGCCCGAGGCCAAGCTTAAC-3’ 
neGFP-XhoI-r:                 5’-gcgcctcgagCTATTTGTATAGTTCATCCATGC-3’ 
Primers for sequencing PDR5::GFP fusion: 
PG-Seq1 –f:                     5’-ACAGAACCGTATCAAGGGTGTC-3’ 
PG-Seq2 –f:                     5’-TTCTTCTCTGTTAGAAATCTTTTCG-3’ 
PG-Seq3 –f:                     5’-TATTTCACTGGAGAAACCTTTGTTACG-3’ 
PG-Seq4 –f:                     5’-GAAAGGTTCGATAACTGCAGCTG-3’ 
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PG-Seq5 –f:                     5’-TCTACGTTTATGTTGGTTCTATGG-3’ 
PG-Seq6 –f:                     5’-GGAAACATTCTTGGACACAAATTGG-3’ 
PG-Seq7 –r:                     5’-CATCTCTCACTGTAGAAAGAATTG-3’ 
PG-Seq8 –r:                     5’-TCAGCTGCAGTTATCGAACCTTTC-3’ 
PG-Seq9 –r:                     5’-CTTCGTAACAAAGGTTTCTCCAGTG-3’ 
PG-SeqA –r:                     5’-AAAAGATTTCTAACAGAGAAGAAAATGC-3’ 
PG-SeqB –r:                     5’-CTATCGACACCCTTGATACGGTTCTG-3’ 
PG-SeqC –f:                     5’-ACTCATGGTTTTGATCTTGGTGCAGATAC-3’ 
PG-SeqD –f:                     5’-TGTACTAACTGAAAAGAATGCAAATGACC-3’ 
PG-SeqE –f:                     5’-ATGGTGCTCATAAATGCCCTGCTGACG-3’ 
Orientation of the insert after inserting into pRS403 (his marker) plasmid: 
Insert-f:                            5’-AATTGGAGCGACCTCATGCTATACCTG-3’ 
Backbone-r:                     5’-CGCGTTGGCCGATTCATTAATGC-3’ 
 
2.1.2 Strains and Media 
The haploid S. cerevisiae strain YPH500 (α, ura3-52, lys2-801, ade2-101, 
trp1Δ63, his3Δ200, and leu2Δ1) (Stratagene) was used as a parental strain. The reporter 
plasmid was integrated into the native Gal1-Gal10 locus first. Then the regulator plasmid was 
integrated into the AmpR gene in the reporter plasmid by homologous recombination. The 
transformation procedure was described before 141. Strains with single integration were selected 
by PCR and flow cytometry. All cell cultures were grown in synthetic drop-out (SD) medium with 
appropriate selection markers and 2% galactose.  
Primers used for strains verification: 
Before2TRP-r:                 5’-CACATATATTACGATGCTGTTCTATTAAATGCTTCC-3’ 
TetREnd-f:                        5’-ATGCGGATTAGAAAAACAACTTAAATGTGAAAGTGG-3’ 
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HIS-f:                                5’-ATGACAGAGCAGAAAGCCCTAGTAAAGC-3’ 
HIS-r:                                5’-CTACATAAGAACACCTTTGGTGGAGGG-3’ 
TRPSeq-f:                         5’-GGTGAAAACCTCTGACACATGCAGCTCC-3’ 
HIS-Begin-r:                     5’-ACGCTTTACTAGGGCTTTCTGCTCTGTC-3’ 
TetR-BamHI-f:                 5’-GCGCGGATCCTATTAAAATGTCTAGATTAGATAAAAG-3’ 
TetR-XhoI-r:                     5’-GCGCCTCGAGTTAAGACCCACTTTCACATTTAAG-3’ 
            
2.1.3 Endogenous Pdr5 knockout 
KanMX4 cassette was used for Pdr5 knockout. This cassette confers resistance to 
geneticin (G418), and was used as selection marker for successful knockout. First of all, a dose 
killing curve was done to optimize geneticin concentration for selection. A series of geneticin 
solution were made with different concentration and used to treat target strains, a positive 
control was used as reference. 200mg/ml geneticin was selected for my target strains. KanMX4 
cassette was amplified to include upstream 45 nucleotides and downstream 45 nucleotides of 
native PDR5 gene. Then the PDR5 specific KanMX4 cassette was transformed into target 
strains to replace endogenous PDR5 gene through homologous recombination. Transformation 
was done with the method describe by R Daniel Gietz’s methods 142. 0.3 µg KanMX4 cassette 
was use for transformation. Deletion of endogenous PDR5 gene was confirmed by PCR.  
Primers used for PDR5 knockout: 
PDR5-deletion-UP45:     
5’-TTAAGTTTTCGTATCCGCTCGTCGAAAGACTTTAGACAAAAATG-3’ 
PDR5-deletion-DN45:      
5’-CATCTTGGTAAGTTTCTTTTCTTAACCAAATTCAAAATTCTATTA-3’ 
PDR5-deletion A:              5’-TTGAACGTAATCTGAGCAATACAAA-3’ 
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PDR5-deletion B:              5’-TACCTAAAACGACTAGCAATTCA-3’ 
PDR5-deletion C:              5’-GCCTCTTTGTTGTTTACAATGTC-3’ 
PDR5-deletion D:              5’-TCACACTAAATGCTGATGCCTAT-3’ 
Kan B:                                 5’-CTGCAGCGAGGAGCCGTAAT-3’ 
Kan C:                                 5’-TGATTTTGATGACGAGCGTAAT-3’ 
 
2.1.4 Site directed mutagenesis 
Reporter plasmid (pDN-G1PGlbh) containing PDR5::GFP fusion gene was modified with 
site directed mutagenesis in order to create non-functional Pdr5 protein. In the first mutant, No. 
4734 nucleotide, cytosine, on the plasmid pDN-G1PGlbh was converted to thymine. In the 
second mutant, the nucleotide No.3997, guanine, on the plasmid pDN-G1PGlbh was converted 
to adenine. This procedure was done with QuikChange II XL Site-Directed Mutagenesis Kit. 
Desired mutation was introduced on one pair of primers, which were used to amplify the entire 
plasmid pDN-G1PGlbh. Then the PCR product was digested with Dpn1 restriction enzyme, 
which recognized parental plasmid (PCR template) and digested it. Then the digested PDR 
product was transferred to XL10-Gold ultracompetent cells which connected the two ends of the 
PCR product and repaired the nick, new plasmid with desired site mutation was created.   
Primers used for site directed mutagenesis: 
PDR5-S558Y-f:          
5’-CTATTTCCGTGGTTATGCTATGTTTTTTGCAATTCTATTCAATGC-3’ 
PDR5-S558Y-r:          5’-CATAGCATAACCACGGAAATAGAATGTAGAAGTATCACC-3’ 
PDR5-G312A-f:         
5’-GTTTCCGGTGCTGAAAGGAAGCGTGTCTCCATTGCTGAAGTCTCC-3’ 
PDR5-G312A-r:         
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5’-CGCTTCCTTTCAGCACCGGAAACACCTCTGACGATGTCGTTACC-3’ 
 
2.1.5 Identification of optimal resuspension period for cell culture 
In order to maintain stable cellular growth condition for the experiments, cells need to be 
kept growing in exponential phase. In order to optimize culturing time and cell density to 
maintain them growing in exponential phase, growth curve was measured. This measurement 
was to determine the starting cell density and the time for each strain to reach saturation in no 
drug and no inducer environment. Cells were streaked on plate with corresponding selection 
marker and 2% glucose, and were grown in 30 °C for 2 days. Single colony was inoculated in 
liquid medium with corresponding selection marker and 2 % glucose, and was grown in 30 °C 
over night. Start new cell culture with cell density at 5*105 cells/ml liquid medium with 
corresponding selection marker and 2% galactose. Cell density was measured by Nexcelum cell 
counter every 2 hours until 24th hour. Growth curve was plotted. Cells kept growing in 
exponential phase up to 16 hours, and then reached saturation. Based on the data, cell culture 
was resuspened every 12 hours to maintain their growth in exponential phase.  
 
2.1.6 Measurement of growth rate  
Cellular growth rate was measured for each strain. Cells were streaked on selection 
plate with 2% glucose, and were cultured in 30 °C for 2 days. Single colony was inoculated in 
liquid medium with corresponding selection marker and 2% glucose in 30 °C overnight. The next 
day, fresh cell culture with cell density at 5*105 cells/ml was started in liquid medium with the 
same selection marker, but 2% galactose. Cell density was measured every 12 hours, and then 
cell cultures were resuspended in fresh medium with starting cell density 5*105 cells/ml. 
Measurement of cell density was done during the entire dose-response experiment. In PFpump 
strain, the growth rate of the two subpopulations was measured as well after cell sorting.  
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2.1.7 Characterization of synthetic gene circuits behavior  
All the cells used for dose response characterization were kept growing in exponential 
phase. Based on the results from growth curve measurement that cells with starting density 
5*105 cells/ml would reach saturation after 16 hours growth, each cell culture was started with 
the same cell density and re-suspended every 12 hours. At each re-suspension, cell number of 
each culture was counted by Nexcelom cellometer and then the cell density was calculated. In 
each re-suspension, new cell culture was started with density 5*105 cells/ml again. In the cases 
that cells were treated with doxycycline or fluconazole, the degradation of both drugs in 30 
degree for 12 hours were both considered when re-suspending cells into new cell culture. A re-
suspension formula was developed to calculate the volume of cells from old cell culture, fresh 
medium, doxycycline or fluconazole at different concentration. In order to avoid system error of 
Nexcelom cellometer cell counter, cell density in culture was diluted to the range of 5*106 
cells/ml to 1.5*107 cells/ml.  
 
2.1.8 Flow cytometry 
Flow cytometry was done every 24 hours for normal dose-response characterization. For 
strains with only GFP fluorescence, FACSCan (Becton Dikinson) was used, while FACSAria II 
(Becton Dikinson) was used for 2 color strains dose-response and Calcein-AM red dye 
experiment to test Pdr5 functionality. Flow cytometry data was used to monitor the expression of 
target gene in the cell population, once the target gene expression became stable, flow 
cytometry data was used to analyze dose-response behavior.  
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2.1.9 Pdr5 function test by Calcein-AM red 
NRpump and NFpump strains were streaked on plate with corresponding selection 
marker and 2% glucose, and were grown in 30 °C for 2 days. Single colony was inoculated in 
liquid medium with corresponding selection marker and 2 % glucose, and was grown in 30 °C 
overnight. Inoculate 10 µl of overnight culture to new synthetic medium with the same selection 
marker and 2% galactose. Cells were induced with the same set of concentrations of 
doxycycline for 3 days. Cells were suspended in fresh medium and inducer every 12 hours. 
Flow cytometry was used to check expression of Pdr5 every 24 hours. When Pdr5 expression 
became stable, cells were collected and washed with pre-cold PBS twice. Then cells were 
suspended in synthetic medium with cell density at 5*105 cells/ml. Then a set of Calcein-AM red 
was added in the cell culture (0 µg/ml, 1 µg/ml, 2µg/ml, 3µg/ml, 4µg/ml and 5µg/ml). Cells were 
cultured for 3 hours and the Calcein-AM red fluorescence intensity was measured every hour. 
YPH500 strain was used as negative control, RFpump strain was used as positive control.  
 
2.1.10 Measurement of cellular memory in PFpump strain 
In order to measure the cellular memory of each subpopulation in PFpump strain, 
PFpump cells were first induced with the doxycycline concentration that gave almost identical 
number of cells in of the two subpopulations. Cell culture was resuspend every 12 hours, and 
Pdr5 expression was monitored by flow cytometry. When the expression became stable, cells 
were sorted into two subpopulations based on a threshold of 500 a.u. The growth rate and 
distribution of Pdr5 expression in the two subpopulations and a non-sorted control was 
measured by counting cell number and flow cytometry every 2 hours in the first 12 hours, and 
then every 12 hours until both of the subpopulations reached the same Pdr5 expression as the 
non-sorted control did.  
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2.2 Data analysis 
2.2.1 FACScan data analysis 
FACScan data was read by matlab code, the value of three parameters, FSC, SSC and 
FL1 (green fluorescence intensity), was extracted. A 10*10 gate based on FSC and SSC was 
applied to the area with highest cell density in each sample in order to exclude extrinsic noise. 
Then fluorescence data was read and processed in the gated area. Frist, the arithmetic mean 
and standard deviation were calculated and any data that was outside 3 times standard 
deviation was considered outliners and therefore excluded from the dataset. Fluorescence 
intensity of YPH500 strain cultured in complete synthetic medium was used as background, and 
then its value was subtracted from the fluorescence intensity of each experimental sample. The 
mean of each sample was then normalized to the sample in its corresponding strain that was 
induced at the highest doxycycline concentration. Finally the mean and CV was calculated and 
plotted against doxycycline concentration that was used for the induction of each strain 
separately.  
 
2.2.2 FACSAria II data analysis 
FACSAria II data was read by matlab code as well. Four parameters, FSC, SSC, FL1 
(green fluorescence intensity) and FL3 (red fluorescence intensity), were extracted. The 
following processing steps were the same as FACScan data processing, except that the mean 
and CV was calculated for both green and red fluorescence intensity, and them plotted vs 
doxycycline concentrations used for each 2 color strain. 
 
2.2.3 Deterministic simulation of GFP expression 
This simulation was based on previous published differential equations 29. 
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Where x, y and z represent TetR, intracellular doxycycline and GFP, b is the binding 
coefficient between TetR and doxycycline, d and f represent degradation coefficient. 
F(x) is inhibitory hill function.  
 ( )  
  
     
 
Where Ɵ is the induction threshold and n is the hill coefficient. The parameters are a 
= 50 nMh-1, b = 3.6 nM-1 h-1, C = 0.6 [doxycycline] h -1, f = 1.2 h-1, Ɵ = 0.44, n = 4, F = 
1.5. 
Here, in order to simulate different fluorescence intensity, I used two GFP 
degradation rate d in the equation above. d = 0.12 h -1 was used in NR 1, d = 1.2 h -1 
was used in NR 2 
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Chapter 3 Effect of protein pump on Negative Regulation (NR) and 
Negative Feedback (NF) gene circuits 
 
3.1 Introduction 
Protein pumps function to exclude intracellular toxins. This property fits the scenario in 
the production of clinical and industrial molecules, over production of which is usually toxic to 
the host organisms, and therefore they need to be excluded to keep the host cells growing at 
the fittest condition. Efforts have been made to select protein pumps in E. coli for the optimal 
production of biofuel molecules 123. However, the work has not been done in eukaryotes to 
control and optimize the exclusion of toxic molecules with a protein pump under the control of 
different regulatory networks. My goal here was to study the interaction between the protein 
pump and the networks that regulate it. Recently this question was addressed computationally 
for a natural gene regulatory network involving positive feedback [20]. To answer this question 
experimentally for additional networks in eukaryotes, I modified two previously characterized, 
TetR-based synthetic gene circuits inducible by tetracycline analogs, called the negative 
regulation (NR), and negative feedback (NF) gene circuits. I first characterized the original 
versions of these gene circuits that control a passive target gene, which does not affect its 
upstream transcriptional regulators. Here, I replaced this passive target gene with the yeast 
pleiotropic drug resistance pump-fluorescent reporter fusion gene PDR5::GFP. Once 
PDR5::GFP is expressed, it pumps out the inducer, altering the activity of its upstream 
transcriptional regulators, creating a feedback loop. We show by experiment and mathematical 
modeling how this feedback loop alters the dose response of synthetic gene circuits. Moreover, 
we identify mechanisms underlying an additional, unexpected difference between the dose-
response curves. 
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3.2 NR and NRpump gene circuit design and dose response in doxycycline  
3.2.1 NR and NRpump gene circuits composition (regulatory network) 
The NR gene circuit is composed of two parts: the reporter and the regulator. The 
reporter consists of the yEGFP and ZeoR fusion gene, yEGFP::ZeoR. This fusion gene is under 
the control of a modified GAL1 promoter, which bears 2 TetR binding sites, TetO, and therefore 
becomes inducible by tetracycline family molecules, such as doxycycline. The regulator 
contains the TetR gene under the control of the natural Gal1 promoter, which is constitutively 
active in the presence of galactose. TetR is a bacterial repressor whose binding with TetO sites 
blocks the transcription. However, TetR will dissociate from TetO sites in the presence of 
doxycycline which is able to bind to TetR competitively, leading to transcription of the 
downstream gene, yEGPF::ZepR (Figure 3.1 A). The NRpump gene circuit has the same 
regulator as the NR gene circuit, which is the TetR gene under the control of the natural GAL1 
promoter. However, the yEGFP::ZeoR fusion gene on the reporter of NR gene circuit was 
replaced by PDR5::GFP fusion gene, while the promoter remained the same modified Gal1 
promoter, which is inducible by doxycycline. Since Pdr5 is able to pump out intracellular 
doxycycline, it introduces another negative feedback loop into the NRpump gene circuit (Figure 
3.1 B).  
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 Figure 3.1 Regulation scheme for synthetic gene circuits 
 (A) Negative Regulation (NR) gene circuit. (B) Negative Regulation pump (NRpump) gene 
circuit.  (C) Negative Feedback (NF) gene circuit. (D) Negative Feedback pump (NFpump) gene 
circuit. 
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3.2.2 NR dose-response 
Although the dose-response of NR has been characterized before 29, it was induced by 
ATc, which is light sensitive and prone to degradation. Here I used doxycycline to induce the 
transcription of the yEGFP::ZeoR gene in the NR gene circuit to see how the yEGFP::ZeoR 
expression in this circuit responds to different doxycycline concentrations. This is called the 
dose-response. Here I used 10 concentrations of doxycycline to induce the expression of 
yEGFP::ZeoR gene in the NR gene circuit. Then the expression level of yEGPF::ZeoR in each 
individual cell was measured and quantified by flow cytometry. At zero and low doxycycline 
concentrations, the expression level of yEGFP::ZeoR was low in each individual cell in the 
whole population. With the increase of doxycycline concentration, a small portion of cells started 
to express a higher level of yEGFP::ZeoR, and the number of high expressing cells and their 
yEGFP::ZeoR expression level kept increasing with further increase of doxycycline 
concentration. When the doxycycline concentration reached intermediate level, some of the high 
expressing cells reached their maximum yEGFP::ZeoR expression level, while a portion of low 
expressing cells remained, and the other cells were in between. With further increase of 
doxycycline concentration, the majority of cells in the population shifted to higher yEGFP::ZeoR 
expression. Where doxycycline concentration was at high level (6 µg/ml), all cells in the 
population became high expressers reaching maximum expression level of yEGFP::ZeoR in 
each individual cell, and the expression remained the same at all the doxycycline concentrations 
above 6 µg/ml. In other words, the NR gene circuit’s expression reached saturation (Figure 3.2).  
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Figure 3.2 Histograms of NR dose-response. 
NR gene circuit was induced at 10 doxycycline concentrations, 0, 2, 4, 4.5, 5, 5.5, 6, 6.5, 7 and 
10 µg/ml; the histograms of yEGFP::ZeoR expression at each doxycycline concentration were 
shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and every 12 hours, cell 
density was measured by Nexolum, a small amount of cell culture based on calculated was 
inoculated into fresh medium to start new culture with the cell density, 0.5 x 106 cells/ml.  
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The mean of each histogram was calculated and plotted versus the corresponding 
doxycycline concentrations. By looking at the mean dose-response plot, we are able to 
understand the change of the mean expression over the entire dose response course. At zero 
and low doxycycline concentration, the means were very low. The only yEGFP::ZeoR 
expression was from gene circuit leakage. However, the population mean showed a steep 
increase at intermediate doxycycline concentration, and reached saturation immediately after 
further increase of doxycycline concentration (Figure 3.3 A). The NR gene circuit was sensitive 
to doxycycline at a narrow concentration range.  The noise of the population was measured by 
the coefficient of variation (CV). CV is defined as the standard deviation divided by the mean, 
and is used to describe the deviation of a population from its mean. Here the CV was calculated 
for each histogram in Figure 3.2 as well. At zero and low doxycycline concentrations, the CV 
was low because all the cells expressed the same level of yEGFP::ZeoR. The CV began to 
increase with the increase of doxycycline concentration, and reached its peak at intermediate 
doxycycline concentration, which corresponded to the most diverse yEGFP::ZeoR expression 
level in the population shown in the histogram (Figure 3.2 E). With further increase of 
doxycycline concentration, the CV bounced back to a low level as indicated by uniformly high 
expression of yEGFP::ZeoR in the whole cell population (Figure 3.3 B).  
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Figure 3.3 The Mean and CV of NR dose-response. 
Doxycycline at 10 different concentration was used to induce yEGPF::ZeoR expression in the 
NR gene circuit: 0, 2, 4, 4.5, 5, 6, 6.5, 7, 10 µg/ml. Doxycycline at 10 different concentrations 
was used to induce PDR5::GFP expression in the NRpump gene circuit: 0, 2, 4, 5, 6, 7, 8, 9, 10, 
and 15 µg/ml. (A) NR Mean dose-response; (B) NR Coefficient of Variation (CV) dose-response. 
(C) NRpump Mean dose-response; (D) NRpump Coefficient of Variation (CV) dose-response. 
Data shown here was an average of 3 replicates. Error bar refers to the SD of the 3 replicates’ 
mean value.  
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3.2.3 NRpump dose response mean and CV 
After obtaining the dose response for the NR gene circuit, I wanted to know if the pump 
would change the   behavior of the NR gene circuit, and if so, how would it change it. In order to 
have a fair comparison, I followed exactly the same experimental procedures as I did for the NR 
gene circuit to characterize the dose-response for the NRpump gene circuit. Initially, the same 
set of the doxycycline concentrations were used to induce the NRpump gene circuit. However, 
NRpump required higher doxycycline concentration to reach saturation compared to NR. 
Therefore, I increased doxycycline concentrations to induce NRpump, and 10 of them were 
selected to represent the dose response behavior. The selected doxycycline concentrations 
were slightly different from the concentrations used to induce NR gene circuit; because Pdr5 
changed the dose-response curve and higher doxycycline concentration was required to 
achieve saturation. At no and low doxycycline concentrations, the expression level of 
PDR5::GFP in each individual cell was at the basal level, and the expression was uniform 
across the whole cell population. At intermediate doxycycline concentrations, a number of cells 
began to express higher PDR5::GFP, while most of the cells in the population remained low 
expression level. With increase of doxycycline concentration, a higher percentage of cells in the 
population expressed high level of PDR5::GFP. When doxycycline concentration was further 
increased, the majority of cells in the population became high PDR5::GFP expressers. At high 
doxycycline concentrations, all the cells in the population expressed a high level of PDR5::GFP, 
and the histograms would not change with any further increase of doxycycline concentration 
after 10 µg/ml.  
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Figure 3.4 Histograms of NRpump dose-response. 
Cells carrying NRpump gene circuit were induced at 10 doxycycline concentrations, 0, 2, 4, 5, 6, 
7, 8, 9, 10 and 15 µg/ml; the histograms of PDR5::GFP expression at each doxycycline 
concentration were shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexolum, a small amount of cell culture based on 
the calculation was inoculated into fresh medium to start new culture with the cell density, 0.5 x 
106 cells/ml.  
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The mean for the NRpump histograms at each doxycycline concentration was calculated 
as for the NR gene circuit. At no and low doxycycline concentrations, the mean was low, then it 
started to increase at doxycycline 4 µg/ml and showed a significant increase from 5 µg/ml to 9 
µg/ml, and then reached saturation  at doxycycline concentration 10 µg/ml (Figure 3.3 C). The 
CV was calculated and plotted versus the doxycycline concentration as well. It was low at zero 
and low doxycycline concentrations, and showed a peak at intermediate doxycycline 
concentration, 4 µg/ml, which corresponded well to the diverse PDR5::GFP expression in the 
cell population at that particular doxycycline concentration, shown on the histogram (Figure 3.4). 
The CV decreased after further increase of doxycycline concentrations and became flat after 6 
µg/ml doxycycline (Figure 3.3 D), which indicated homogenous PDR5::GFP expression. 
 
3.2.4 Dose response comparison between NR and NRpump strains 
Since the mean and CV for NR and NRpump gene circuits were all calculated and 
plotted, I could compare them side by side after normalization. At zero and low doxycycline 
concentrations, both NR and NRpump showed low fluorescence intensity mean (low target gene 
expression). However, at doxycycline concentration 4 µg/ml, NRpump started to respond while 
NR still remained at low expression (Figure 3.5 A). With increasing doxycycline concentration, 
the dose response mean of NR showed a steep increase and reached saturation right after it. 
However, compared to NR, the NRpump dose response mean showed a relatively slower 
increase, and reached saturation at higher doxycycline concentration.  In other words, NRpump 
was more sensitive to doxycycline induction than NR at low doxycycline concentrations, but 
became less sensitive at high doxycycline concentrations. Besides, NRpump has a wider dose 
response range for doxycycline induction, between 4 µg/ml and 10 µg/ml, which was 4.5 µg/ml 
to 7 µg/ml for NR (Figure 3.5 A). Gene expression noise, measured by the CV, peaked at a 
slightly lower intermediate doxycycline concentration and reached a lower maximum for 
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NRpump than for NR (Figure 3.5 B). The lower CV peak for NRpump could be due to weaker 
GFP fluorescence intensity of the PDR5::GFP fused protein than of yEGFP in NR, which 
caused less broad distributions when the basal expression does not change. Another reason for 
the lower CV could be pump-mediated negative feedback (negative feedback, known to reduce 
noise). The broad histograms at intermediate doxycycline concentrations indicated 
heterogeneous reporter expression in individual cells and were consistent with the CV peaks 
(Figures 3.5 C and D). Therefore, the efflux pump, Pdr5, managed to change the dose response 
behavior of the NR gene circuit.  
 
3.2.5 ODE models demonstrating effect of GFP fluorescence intensity   
Since NR and NRpump used different GFP connected to the target protein, the 
two versions of GFP differed in their green fluorescence intensity. In order to 
compare the dose-response of NR and NRpump, I normalized fluorescence intensity 
at each doxycycline concentration to the fluorescence intensity at  highest doxycycline 
concentration used in the experiment for each strain. Here I want to demonstrate that 
the different fluorescence intensity does not affect the dose-response curve after 
normalization. In order to do that, I first used previously establ ished mathematical 
models to simulate two NR dose-responses, NR1 and NR2, then used different 
degradation rate for GFP in the two NR dose-responses, which resulted in different 
GFP fluorescence intensity. As a result, NR1 and NR2 have different GFP 
fluorescence intensity (Figure 3.6 A). However, they show exactly the same dose-
response after normalization (Figure 3.6 B). 
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Figure 3.5 NR and NRpump mean and CV dose-response and histograms. 
Doxycycline at 10 different concentrations were used to induce yEGFP::ZeoR expression in NR 
gene circuit: 0, 2, 4, 5, 6, 7, 8, 9, 10 and 15 µg/ml. (A) NR and NRpump Mean dose-response; 
(B) NR and NRpump Coefficient of Variation (CV) dose-response. (C) Histogram of NR Mean 
dose-response. (D) Histogram of NRpump Mean dose-response. Data shown here was average 
of 3 replicates. Error bar refers to the SD of the 3 replicates’ mean value. 
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Figure 3.6 NR dose-response simulations. 
 (A) NR1 and NR2 Mean dose-response; (B) Normalized NR1 and NR2 Mean dose-response. 
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3.3 NF and NFpump gene circuits’ design and dose-response in 
doxycycline  
3.3.1 NF and NFpump gene circuit composition 
Same as the NR gene circuit, the NF gene circuit is composed of two parts as well, the 
regulator and the reporter. It shares the same reporter with the NR gene circuit. However, the 
difference between NR and NF gene circuits is that the natural GAL1 promoter driving TetR 
expression in the NR gene circuit was replaced by the modified GAL1 promoter bearing TetO 
sites in the NF gene circuit (Figure 3.1 A and C). Therefore, both yEGFP::ZeoR and TetR genes 
were under the control of the same doxycycline inducible promoter. In this case, TetR is able to 
repress the transcription of both yEGFP::ZeoR and itself. When doxycycline appears, it binds to 
TetR and releases it from the TetO sites, therefore, leading to the transcription of the 
yEGFP::ZeoR gene in the NFpump gene circuit. The NFpump gene circuit was also composed 
of the regulator and the reporter. The regulator shares the same components as the NF gene 
circuit, namely TetR gene under the control of modified GAL1 promoter, (GAL1 promoter with 2 
TetO sites). The GAL1 promoter is able to transcribe the downstream gene in the presence of 
galactose. However, when TetR is present, it binds to the TetO sites and repress the 
transcription. In the report of NFpump gene circuit, PDR5::GFP fusion gene was used to replace 
the yEGFP::ZeoR fusion gene in NF gene circuit, while the promoter remained the same, 
modified Gal1 promoter (Figure 3.1 C and D). When doxycycline appears, it binds to TetR and 
releases its binding with TetO sites on the modified GAL1 promoter, which initiated the 
transcription of downstream PDR5::GFP gene.  
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3.3.2 NF gene circuit dose-response 
The NF gene circuit was induced with 10 doxycycline concentrations. At all doxycycline 
concentrations, the expression level of yEGFP::ZeoR in individual cells was uniform, meaning 
that there was only one peak in the fluorescence intensity histogram. At zero doxycycline 
concentration, yEGFP::ZeoR expression was at the basal level in the whole cell population.  
With gradual increase of doxycycline concentration, the expression level of yEGFP::ZeoR in 
each individual cell shifted to higher fluorescence intensity gradually until it reached saturation 
at doxycycline 4 µg/ml (Figure 3.7). After the saturation point, further increase of doxycycline 
concentration did not change the expression level of yEGFP::ZeoR in the cells anymore.  
Then fluorescence intensity mean and CV for the histograms at each doxycycline 
concentration were calculated and plotted. The mean dose-response of NF was different from 
that of NR. Between doxycycline concentration 0 µg/ml and 4 µg/ml, the mean showed a linear 
dose response, and it reached saturation at 5 µg/ml (Figure 3.8 A). The data shown here was 
from 3 independent replicates, all the 3 replicates showed linear dose response range between 
0 µg/ml and 4 µg/ml, but with slight difference in the slope of the curves, which contributed to 
the error bar (Figure 3.8 A). The CV dose-response was very low at all the doxycycline 
concentration, which corresponded well to the uniformly distributed histograms regarding 
yEGFP::ZeoR expression (Figure 3.8 B).  
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Figure 3.7 Histograms of NF dose-response. 
Cells carrying NFpump gene circuit were induced at 10 doxycycline concentrations, 0, 0.5, 1, 
1.5, 2, 2.5, 3, 4, 5 and 6 µg/ml; the histograms of PDR5::GFP expression at each doxycycline 
concentration were shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexolum, a small amount of cell culture based on 
the calculation was inoculated into fresh medium to start new culture with the cell density, 0.5 x 
106 cells/ml.  
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Figure 3.8 NF and NFpump mean and CV dose-responses.  
Doxycycline at 10 different concentration were used to induce yEGFP::ZeoR or PDR5::GFP 
expression in NF and NFpump gene circuits: 0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5 and 6 µg/ml. (A) NF 
Mean dose-response; (B) NF Coefficient of Variation (CV) dose-response. (C) NFpump Mean 
dose-response; (D) NFpump Coefficient of Variation (CV) dose-response. Data shown here was 
average of 3 replicates. Error bar refers to the SD of the 3 replicates’ mean value. 
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3.3.3 NFpump dose-response 
After obtaining the dose response curve of the NF gene circuit, I asked if Pdr5 would be 
able to alter it as for NR.  I followed the same experimental procedure to characterize the dose 
response behavior for the NFpump gene circuit. Similar to the NF gene circuit, the histograms at 
each of the doxycycline concentrations showed only one peak, meaning that all the cells 
expressed the same level of PDR5::GFP at every doxycycline concentration.  Besides, the 
histogram shifted to higher expression level of PDR5::GFP gradually with gradual increase of 
doxycycline concentration, until it reached saturation at doxycycline concentration 4 µg/ml 
(Figure 3.9).  
The fluorescence intensity mean for NFpump histograms at each doxycycline 
concentration was calculated. The mean increased gradually with the increasing of doxycycline 
concentration, and reached saturation at doxycycline concentration 4 µg/ml. The gene 
expression noise, CV, was calculated and plotted against the doxycycline concentration as well. 
It remained low at all the doxycycline concentrations, which indicated the uniform expression 
level of PDR5::GFP in the cell populations, and corresponded well to the histograms (Figure 3. 
C). The CV remained low during the entire range of doxycycline concentrations (the slightly 
higher CV at no and low doxycycline might due to the system error in FACScan flow cytometer) 
(Figure 3.8 D).  
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Figure 3.9 Histogram of NFpump dose-response. 
Cells carrying NFpump gene circuit were induced at 10 doxycycline concentrations, 0, 0.5, 1, 
1.5, 2, 2.5, 3, 4, 5 and 6 µg/ml; the histograms of PDR5::GFP expression at each doxycycline 
concentration were shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexolum, a small amount of cell culture based on 
the calculation was inoculated into fresh medium to start new culture with the cell density, 0.5 x 
106 cells/ml.  
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3.3.4 Dose-response comparison between NF and NFpump strains 
In the prior section, it was shown that Pdr5 was able to change the dose-response 
behavior of the NR gene circuit; I was curious how it could alter the dose-response for the NF 
gene circuit. Since the mean and CV for NF and NFpump gene circuits were all calculated and 
plotted, I could compare them side by side. One obvious difference in the mean dose-response 
mean was that the NF gene circuit showed a linear dose response range between doxycycline 
concentration 0 µg/ml and 4 µg/ml, but the linear range disappeared in the dose response of the 
NFpump gene circuit. The dose response mean of the NFpump gene circuit had a concave 
curve. It had higher slope at low doxycycline concentrations compared to the NF gene circuit, 
which might indicate higher sensitivity to doxycycline or higher intracellular doxycycline 
concentration in the cells bearing NFpump gene circuit.  Both the NF and NFpump gene circuits 
reached saturation at the same concentration of doxycycline (Figure 3.10 A). Gene expression 
noise, measured by the CV, was low at all the doxycycline concentrations for both NF and 
NFpump gene circuits (Figure 3.10 B). The slightly higher CV for NFpump gene circuit might be 
due to weaker GFP fluorescence of the Pdr5::Gfp protein fusion than of yEGFP in NF, causing 
less broad distributions when the basal expression does not change. Another reason for the 
lower CV could be pump-mediated negative feedback (negative feedback, known to reduce 
noise). The broad histograms at intermediate doxycycline concentrations indicated 
heterogeneous reporter expression in individual cells and are consistent with the CV peaks 
(Figures 3.10 C and D). In conclusion, the efflux pump, Pdr5, changed the dose response 
behavior for NF gene circuit as well.  
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Figure 3.10 NF and NFpump mean and CV dose-responses and histograms. 
(A) NF and NFpump Mean dose-responses. (B) NF and NFpump CV dose-responses. (C) NF 
histograms in increasing concentration of doxycycline. (D) NFpump histograms in increasing 
concentrations of doxycycline. Error bar refers to the SD of the 3 replicates’ mean value. 
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3.4 NRpump mutant gene circuits and characterization of their dose-
response 
From the comparison between the original NR and NF gene circuits and their pump 
counterparts, the NRpump and NFpump gene circuits, we saw that Pdr5 changed the dose-
response behavior. In order to find out if the change was because of the efflux pumping activity 
of Pdr5, I decided to create Pdr5 mutant with no efflux pumping function. I found two published 
mutations on Pdr5 that disrupt its efflux pumping activity, S558Y and G312A.  It was reported 
that S558Y locates on the transmembrane helix 2 (TMH2) of PDR5 gene, Pdr5 with this mutant 
has normal ATPase activity and drug binding capability, but has impaired coupling between ATP 
hydrolysis and the conformational changes in the transmembrane domains (TMDs) 143. 
Therefore, it blocked the efflux pumping activity of Pdr5. Another study identified the G312A 
mutation in the signature region of the canonical ATP-binding site disrupted ATPase activity and 
therefore drug transport 144.  Strains with S558Y or G312A mutants showed hypersensitivity to 
drug treatment compared to the strain bearing wild type Pdr5, as the same as the strain with 
Pdr5 null mutant 143, 144. Therefore, I replaced the functional PDR5::GFP fusion gene in the 
NRpump and NFpump gene circuits with the mutated PDR5 gene fused with the GFP gene, 
creating the NRpump mutant and NFpump mutant gene circuits.  In order to ensure that the 
PDR5 mutant::GFP fusion gene has abolished efflux pumping activity, two versions of mutants 
were built for NRpump-mutant, NRpump-S558Y and NRpump-G312A. The same was done for 
NFpump-mutant.  
 
3.4.1 NRpump-mutant gene circuit composition 
Because the two mutations were both confirmed to compromise efflux pumping activity 
of Pdr5, two versions of mutant gene circuits were built with each one bearing one single 
mutation. The NRpump-mutant gene circuits share the same regulator with the NRpump gene 
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circuit. The only difference is in the reporter, the PDR5::GFP fusion gene in NRpump gene 
circuit was replaced by PDR5 mutant::GFP fused gene, PDR5-S558Y::GFP or PDR5-
G312A::GFP. In the presence of galactose, TetR was expressed from the Gal1 promoter, and it 
could bind to the TetO2 sites on the modified GAL1 promoter on the reporter (Figure 3.11 A and 
B). When doxycycline was present, it associated with TetR and therefore, released its binding to 
the TetO sites As a result, the downstream PDR5-mutation::GFP gene was able to be 
transcribed. However, since Pdr5 mutants were not able to pump out doxycycline, the two 
NRpump-mutant gene circuits lose the additional negative feedback that wild type Pdr5 
generated. 
 
3.4.2 NRpump mutant gene circuits dose-response 
It has been discovered that Pdr5 pumps out tetracycline family molecules including 
doxycycline, therefore, I asked if the efflux pumping function of Pdr5 protein was the cause of 
the dose-response behavior change in NRpump. In order to test that, I characterized the dose-
response for NRpump-mutant gene circuits and expected the dose-response behavior would 
maintain that of the NR gene circuit.  
First, both NRpump-312 and NRpump-558 strains were induced with the same series of 
doxycycline concentration as it was used for NRpump. The level of PDR5-G312A::GFP 
expression was measured by Flow Cytometry at each doxycycline concentration. At no and low 
doxycycline concentration, PDR5-G312A::GFP expression was low in the whole cell population. 
At intermediate doxycycline concentration, some cells in the population showed increased level 
of PDR5-G312A::GFP expression, while the majority of cells still remained at low expression 
level. With further increase of doxycycline concentration, more cells shifted to high PDR5-
G312A::GFP expression with only a very small percentage of cells staying at low PDR5-
G312A::GFP expression. At high doxycycline concentration, all the cells in the population had 
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high PDR5-G312A::GFP expression expressers, and fluorescence intensity stayed the same 
with further increase of doxycycline concentration, meaning that the level of PDR5-G312A::GFP 
expression reached maximum in each individual cell (Figure 3.12). 
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Figure 3.11. Regulation scheme for Negative Regulation pump mutant (NRpump-mutant) 
and Negative Feedback pump mutant (NFpump-mutant) gene circuits. 
(A) NRpump-312. (B) NRpump-558. (c) NFpump-312. (D) NFpump-558. 
 
 
 
 
 
 
 
 
 
 
 
 
 
57 
 
A B C D 
    
E F G H 
    
I J   
  
  
 
Figure 3.12 Histograms of NRpump-312 dose-response. 
Cells carrying NRpump-312 gene circuit were induced at 10 doxycycline concentrations, 0, 2, 4, 
5, 6, 7, 8, 9, 10 and 15 µg/ml; the histograms of PDR5::GFP expression at each doxycycline 
concentration were shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexolum, a small amount of cell culture based on 
the calculation was inoculated into fresh medium to start new culture with the cell density, 0.5 x 
106 cells/ml. 
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Figure 3.13 Histograms of NRpump-558 dose-response. 
Cells carrying NRpump-558 gene circuit were induced at 10 doxycycline concentrations, 0, 2, 4, 
5, 6, 7, 8, 9, 10 and 15 µg/ml; the histograms of PDR5::GFP expression at each doxycycline 
concentration were shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexolum, a small amount of cell culture based on 
the calculation was inoculated into fresh medium to start new culture with the cell density, 0.5 x 
106 cells/ml. 
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The histograms of NRpump-558 reporter expression were very similar to NRpump -312. 
At no and low doxycycline concentration, all the cells in the population expressed a minimum 
level of PDR5-S558Y::GFP.  At intermediate doxycycline concentration (4 µg/ml), a minority of 
cells started to express a higher level of PDR5-S558Y::GFP while the rest of the cells still 
remained at low PDR5-S558Y::GFP expressers. With increasing of doxycycline concentration (5 
µg/ml), around half of the cells in the population expressed high level of PDR5-S558Y::GFP, 
while the other half expressed at low level. As doxycycline concentration was further increased 
(6 µg/ml), the majority of cells in the population had high PDR5-S558Y::GFP expression, with 
only a small fraction of cells expressing low level of PDR5-S558Y::GFP. At high doxycycline 
concentration, all the cells expressed high level of PDR5-S558Y::GFP, and the level of 
expression would reached its maximum. Further increases of doxycycline concentration would 
not increase fluorescence intensity in individual cells (Figure 3.13).  
 
Then I calculated the mean of each histogram for both NRpump-312 and NRpump-558 
at each doxycycline concentration. At doxycycline concentrations of 0 µg/ml and 2 µg/ml, both 
NRpump-mutant strains showed minimum fluorescence intensity (Figure 3.14 A and C). Both 
mutant gene circuits started to respond to doxycycline at 4 µg/ml, and showed steep rise in 
dose response mean with increase of doxycycline concentration between 4 µg/ml and 7 µg/ml. 
Then the dose response mean kept rising, but with much slower pace until it reached saturation 
at doxycycline concentration 9 µg/ml. The error bar at middle doxycycline concentration range 
indicated relatively high variation, which might be due to individual variability of different 
colonies. The error bar would be narrow down with more dose response data from replicates. 
The dose response CV was also calculated for both mutant gene circuits at each doxycycline 
concentration. Both CVs showed a peak at doxycycline concentration 4 µg/ml, which 
corresponded well with the diverse gene expression shown on the histograms (Figure 3.13). 
The CVs were low at both low and high doxycycline concentration, because the gene 
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expression level in the cell population was uniform at both situations. However, the CVs at low 
doxycycline centration were relatively higher than CVs at high concentration, which might be 
due to the low dose response mean (Figure 3.14 B and D). CV was defined as standard 
deviation divided by the mean, even the standard deviation was the same for the histogram at 
both low and high doxycycline concentration, the CV at low doxycycline concentration would be 
higher than the CV at high concentration.  
 
When I aligned the dose response mean together for both NRpump mutant gene 
circuits, the two curves showed exactly the same pattern and overlapped, which suggested that 
the two mutations, S558Y and G312A, altered Pdr5 function the same way, although different 
underlying mechanisms were proved. The CV of both mutant gene circuits showed the same 
pattern as well. The only difference was that the CV for Nrpump-312 was slightly higher at no 
and low doxycycline concentration, which suggested slightly higher expression noise of the 
target gene.  
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Figure3.14 NRpump mutants mean and CV dose-responses. 
Doxycycline at 10 different concentration were used to induce PDR5::GFP expression in NR 
gene circuit: 0, 2, 4, 5, 6, 7, 8, 9, 10, 15 µg/ml. (A) NRpump-312 and NRpump-558 Mean dose-
response; (B) NRpump-312 and NRpump-558 Coefficient of Variation (CV) dose-response. 
Data shown here was average of 3 replicates. Error bar refers to the SD of the 3 replicates’ 
mean value. 
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3.5.1 NFpump mutant gene circuits composition 
As for the NRpump mutant gene circuits, two versions of NFpump mutant gene circuits 
were built with one bearing S558Y mutation, and the other bearing the G312A mutation on 
PDR5.  The NFpump mutant gene circuits share the same regulator with the NFpump gene 
circuit. The only difference is in the reporter, the PDR5::GFP fusion gene in NRpump gene 
circuit was replaced by the PDR5 mutant::GFP fused gene, PDR5-S558Y::GFP or PDR5-
G312A::GFP. In the presence of galactose, TetR was expressed under the Gal1 promoter, and 
it bound to the TetO2 sites on the modified GAL1 promoter on the reporter. When doxycycline 
came in, it associated with TetR and therefore, released its binding to the TetO2 sites. As a 
result, the downstream PDR5-mutation::GFP gene was able to be transcribed (Figure 3.11 C 
and D).  
 
3.5.2 NFpump mutants dose-response 
The dose-response mean of NF gene circuit was linear from doxycycline concentration 0 
µg/ml to 4 µg/ml. However, the dose-response mean of NFpump gene circuit was no longer 
linear. It was clear that the Pdr5 pump changed the dose-response behavior. Because it was 
known that Pdr5 pumps out the inducer, doxycycline, we assumed that the efflux pumping 
activity of Pdr5 was responsible for this change. The two mutations, S558Y and G312A, were 
proved to abolish the efflux pumping activity, so we expected the mutation would restore 
linearity of the NF gene circuit mean dose-response mean. In other words, the mean dose-
responses of NFpump mutant gene circuits were expected to be linear between doxycycline 
concentration 0 µg/ml and 4 µg/ml.   
Two NFpump mutant strains were induced by the same series of doxycycline 
concentration as it was used for NFpump. At all of the doxycycline concentrations, the 
expression level of PDR5-mutation::GFP in both mutants showed single peaked distribution. At 
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0 µg/ml doxycycline concentration, the cells in both mutant circuits showed minimum expression 
level of Pdr5 mutant. With gradual increase of doxycycline concentration, the expression level of 
Pdr5 mutant in each individual cell increased accordingly, until it reached maximum expression 
level at doxycycline concentration 2.5 µg/ml. Then the Pdr5 mutant expression in each cell in 
both mutant gene circuits remained stable, further increase of doxycycline concentration did not 
increase its level.  (Figure 3.15, Figure 3.16).  
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Figure 3.15 Histograms of NFpump-312 dose-response. 
Cells carrying NFpump-312 gene circuit were induced at 10 doxycycline concentrations, 0, 0.5, 
1, 1.5, 2, 2.5, 3, 4, 5 and 6 µg/ml; the histograms of PDR5::GFP expression at each doxycycline 
concentration were shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexolum, a small amount of cell culture based on 
the calculation was inoculated into fresh medium to start new culture with the cell density, 0.5 x 
106 cells/ml. 
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Figure 3.16 Histograms of NFpump-558 dose-response. 
Cells carrying NFpump-558 gene circuit were induced at 10 doxycycline concentrations, 0, 0.5, 
1, 1.5, 2, 2.5, 3, 4, 5 and 6 µg/ml; the histograms of PDR5::GFP expression at each doxycycline 
concentration were shown. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexolum, a small amount of cell culture based on 
the calculationas inoculated into fresh medium to start new culture with the cell density, 0.5 x 
106 cells/ml. 
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Then the mean of each histogram at every doxycycline concentration was calculated for 
both mutant gene circuits. The dose response mean for both gene circuits showed a linear 
range between doxycycline concentrations 0 µg/ml and 1.5 µg/ml, and then they both began to 
curve until they reached saturation at 3 µg/ml. Further increase of doxycycline concentration did 
not increase Pdr5 mutant expression level in each individual cell. The CV for both mutant gene 
circuits was low at all doxycycline concentrations. The slightly increased CV at no and low 
doxycycline concentration was due to lower mean. Next, I compared the dose-responses of the 
two NFpump-mutants, they showed the same dose-response curve in terms of both mean and 
CV (Figure 3.17). 
 
3.6 Dose-response comparison among NR, NRpump and NRpump mutants 
Knowing that the Pdr5 mutants lost efflux pumping function, I measured and compared 
the dose-responses of reporter expression mean and CV of NRpump and NRpump mutants. 
The experimental results indicated that both NRpump mutants had similar mean dose-
responses as NR did at high inducer concentrations; and they were steeper compared to the 
mean dose-response of NRpump. However, both NRpump mutants responded to doxycycline at 
a lower concentration compared to NR, but similar to NRpump (Figure 3.18 A).  The CV dose-
responses were similar for all the 4 strains, with the CV of NR peaked at slightly higher 
doxycycline concentration (Figure 3.18 B). This might be due to high GFP fluorescence intensity 
in NR, and higher inducer sensitivity of NRpump and NRpump mutants. This result confirmed 
that the efflux pumping function of Pdr5 caused the dose-response change in high doxycycline 
concentrations in NRpump, but was not the cause for higher sensitivity at low doxycycline 
concentrations.  
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Figure 3.17 NFpump mutants mean and CV dose-response. 
Doxycycline at 10 different concentrations were used to induce PDR5::GFP expression in cells 
carrying NFpump mutants gene circuit: 0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5 and 6 µg/ml. (A) NRpump-
312 and NRpump-558 Mean dose-response; (B) NRpump-312 and NRpump-558 Coefficient of 
Variation (CV) dose-response. Data shown here was average of 3 replicates. Error bar refers to 
the SD of the 3 replicates’ mean value. 
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Figure 3.18 Mean and CV dose-responses comparison among NR, NRpump and 
NRpump-mutants. 
(A) NR, NRpump and NRpump-mutant Mean dose-responses. (B) NR, NRpump and NRpump-
mutant CV dose-responses. Doxycycline at 10 different concentrations were used to induce 
yEGFP::ZeoR expression in cells carrying NR gene circuit: 0, 2, 4, 4.5, 5, 5.5, 6, 6.5, 7 and 10 
µg/ml. Another 10 different doxycycline concentrations were used to induce PDR5::GFP 
expression in cells carrying NRpump and NRpump mutant gene circuits: 0, 2, 4, 5, 6, 7, 8, 9, 10 
and 15 µg/ml. Data shown here was average of 3 replicates for each strain. Error bar refers to 
the SD of the 3 replicates’ mean value. 
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From the above comparison among the four strains in the NR series, the NRpump and 
two NRpump mutants were more inducer-sensitive to doxycycline than NR was at low 
concentration (Figure 3.18). In order to prove that, I applied one-way ANOVA at doxycycline 
concentration 4 µg/ml (Figure 3.19 A) to the data. The mean value of NRpump and the two 
NRpump mutants were all significantly higher than the mean of NR (Table 1). On the contrary, 
NRpump appeared lower mean value compared to the mean of other three strains (Figure 3.19 
A), which was confirmed also by one way ANOVA (Table 2).  
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Figure 3.19 Mean dose-response among NR, NRpump and NRpump-mutant at low and 
high doxycycline concentration. 
(A) Doxycycline concentration at 4 µg/ml. (B) Doxycycline concentration at 7 µg/ml. One-way 
ANOA was performed for all of the four NR related strains at the specified doxycycline 
concentrations.  
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 NR NRpump NRpump-312 NRpump-558 
NR  0.000141 0.000005 0.000029 
NRpump 0.000141  0.004280 0.126933 
NRpump-312 0.000005 0.004280  0.055482 
NRpymp-558 0.000029 0.126933 0.055482  
 
Table 1 ANOVA test for NR, NRpump and NRpump-mutants at doxycycline concentration 
4 µg/ml. 
Numbers showed in the table are p values calculated by ANOVA. P values less than 0.05 
indicates significant difference, which were shown in red. 
 
 
 NR NRpump NRpump-312 NRpump-558 
NR  0.014598 0.199901 0.388194 
NRpump 0.014598  0.126416 0.059865 
NRpump-312 0.199901 0.126416  0.640887 
NRpymp-558 0.388194 0.059865 0.640887  
 
Table 2 ANOVA test for NR, NRpump and NRpump-mutants at doxycycline concentration 
7 µg/ml. 
Numbers showed in the table are p values calculated by ANOVA. P values less than 0.05 
indicates significant difference, which were shown in red. 
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3.7 Dose-response comparison among NF, NFpump and NFpump mutant 
strains 
Compared to NFpump, the mean dose-responses of both NFpump mutant gene circuits 
had a linear range between doxycycline concentrations 0 µg/ml and 1.5 µg/ml, and saturated at 
3 µg/ml (Figure 3.20 A). This result indicated that the deviation from linear dose-response mean 
curve can be attributed to the protein’s efflux pumping function. However, the slopes of the 
linear ranges in both NFpump mutants were larger than that in NF, which suggested that the 
non-functional pump increased somehow the sensitivity of the NF gene circuit to the doxycycline 
concentration, similar to the functional pump. The gene expression noise for both NFpump-
mutants was low as it was for both the NF and NFpump gene circuits, which was consistent with 
the narrow and uniform distributions of reporter expression, observed by single cell-level 
measurements (Figure 3.20 B). However, the dose-response mean curves of NFpump mutants 
did not completely overlap with that of NF as expected. Instead, the NFpump mutants shower 
higher sensitivity to doxycycline at low concentration compared to NF, and their sensitivity was 
at the same level as for NFpump, indicated by the slope of dose-response mean curves at low 
doxycycline concentration (Figure 3.20 A). This data suggested the existence of other factors 
beyond the efflux pumping function of Pdr5 that affected the dose-response change in NFpump 
compared to NF. In summary, functional Pdr5 changed the linearity of dose-response mean by 
efflux pumping activity, but the increased sensitivity to doxycycline was caused by other factors 
instead of the efflux pumping function of Pdr5. 
As validated above, NF has a linear range of mean dose-response, which was lost in 
NFpump, and restored in NFpump mutants, but with a narrower linear range. In order to quantify 
the change of linear range of dose-response mean for NF, NFpump and NFpump-mutant gene 
circuits, I calculated the L1 norm. The idea of L1 norm was to compare the mean dose-response 
of the gene circuits to an ‘ideal’ linear curve that would produce perfectly linear dose-response. 
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Then the experimental data of these 4 gene circuits was compared to the perfect line, and the 
area between the perfect line and each dose-response curve at every doxycycline concentration 
was calculated. The smaller the area was, the more linear the dose-response would be. 
Therefore, zero area would be an indicator for perfectly linear dose-response. As a result, NF 
showed a linear dose-response up to 80% of saturation (Figure 3.21 A), NFpump showed linear 
range up to 40% saturation (Figure 3.21 B), while the linear range for both NFpump-mutants 
ended between 60% and 70% saturation (Figure 3.21 C and D). The results again showed that 
Pdr5 altered the linear dose-response of NF gene circuit, and Pdr5 mutants with compromised 
efflux pumping function restored part of the linear dose-response range, but not all. The four 
strains showed different L1 norm value when they reached 100% saturation. The actual L1 
norm value at 100% saturation reflected the speed for the gene circuits to reach saturation. The 
higher the L1 norm value was, the less doxycycline concentration the gene circuit needs to 
reach saturation. For example, the L1 norm for NF at 100% was around 1, while it was above 
1.5 for NFpump-mutant, meaning that NFpump-mutant reached saturation at less doxycycline 
concentration compared to NF.  
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Figure 3.20 Dose-response comparison among NF, NFpump and NFpump-mutant. 
(A) NF, NFpump and NFpump mutants Mean dose-responses. (B) NF, NFpump and NFpump-
mutant CV dose-responses. Doxycycline at 10 different concentrations were used to induce 
target gene expression in NF, NFpump and NFpump mutants: 0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5 and 6 
µg/ml. Data shown here was an average of 3 replicates for each strain. Error bar refers to the 
SD of the 3 replicates’ mean value. 
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Figure 3.21 L1 norm for NF, NFpump and NFpump-mutants mean dose-responses. 
(A) NF L1 norm; (B) NFpump L1 norm;  (C) NFpump-312 L1 norm; (D) NFpump-558 L1 norm. 
L1 norm was calculated and plotted in matlab.  
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In order to prove that the mean dose-responses for NF, NFpump and the two NFpump-
mutant gene circuits are different, I used one way ANOVA based on the L1 norm at the lowest 
doxycycline concentration where all four strains reached saturation, 5 µg/ml. The L1 norm for 
NF was the lowest among the four; NFpump-mutants showed the highest L1 norm while 
NFpump was in between (Figure 3.22). The ANOVA test showed that the L1 norm of both NF 
and NFpump were different from the other three, the L1 norms of two NFpump-mutants were 
not different from each other, but they were both different from NF and NFpump.  
 
 
 
 
 
Figure 3.22 L1-norm of NF, NFpump and NFpump-mutant mean dose-responses. 
One way ANOVA test was done at doxycycline concentration 5 µg/ml, where all of the four 
strains reached saturation.  
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 NF NFpump NFpump-312 NFpump-558 
NF  0.000166 0.000166 0.000166 
NFpump 0.014598  0.000166 0.000166 
NFpump-312 0.000166 0.000197  0.99203 
NFpymp-558 0.000166 0.000166 0.99203  
 
Table 3 ANOVA test for the linearity of NF, NFpump and NFpump-mutant mean dose-
responses. 
Numbers showed in the table are p values calculated by ANOVA. P values less than 0.05 
indicates significant difference, which were shown in red. 
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3.8 Investigation on other factors that contribute to the dose-response 
mean in NFpump  
The NF strain showed a linear mean dose-response ranging between 
doxycycline concentrations 0 µg/ml and 4 µg/ml (Figure 3.20 A). On the contrary, 
NFpump lost the linear dose-response; instead, it showed a concave curve of mean 
dose-response, which had higher sensitivity to doxycycline than NF at low 
doxycycline concentration (Figure 3.20 A). NFpump-mutants with compromised efflux 
pumping function of Pdr5 restored linear range for dose-response mean, but the 
linear range covered a narrower range of doxycycline concentrations (0 µg/ml to 2 
µg/ml) compared to NF (0 µg/ml to 4 µg/ml). Moreover, the slope of the linear dose-
response range in NFpump-mutants is higher than the slope of NF (Figure 3.20 A), 
which indicated higher sensitivity to doxycycline at low concentration. Interestingly, 
this sensitivity in NFpump-mutants is the same as NFpump. These results suggested 
the existence of another mechanism that also contributed to the change of dose -
response mean in NFpump compared to NF, besides the efflux pumping function of 
Pdr5.  
My collaborator created stochastic simulations of dose-response for all the NR 
series and NF series strains based on previous research 145, which were able to 
reproduce my experimental results. On the basis of these models, he performed 
sensitivity analysis and tested if TetR concentration was lower in pump and pump-
mutant strains compared to their non-pump counterparts, then he matched the data. 
In order to test the hypothesis that reduced TetR expression contributes to the dose-
response change in pumps trains, I created 2-color gene circuits representing all of 
the 8 gene circuits used before, by fusing TetR with mCherry and replacing the 
original TetR on these gene circuits (Figure 3.23).  
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Figure 3.23 Regulation scheme for 2-color gene circuits. 
 (A) NR. (B) NRpump. (C) NRpump-312. (D) NRpump-558. (E) NF. (F) NFpump. (G) NFpump-
312. (H) NFpump-558 
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3.8.1 Two-color NR and NF gene circuits and their TetR expression 
2-color NR and NF strains were induced by the same concentration of doxycycline used 
for single color NR and NF strains respectively, and their TetR expression was measured by 
flow cytometry. In the NR strain, TetR expression was similar across the entire range of 
doxycycline concentrations, even in the absence of doxycycline (Figure 3.24 A). Because TetR 
was under the control of the wild type GAL1 promoter, it was constitutively expressed in the 
presence of galactose. TetR expression in the NF strain was at the basal level in the absence of 
doxycycline, and it rose with the increase of doxycycline concentration. The increase showed a 
linear dose-response range between doxycycline concentrations 0 µg/ml and 2.5 µg/ml, and 
then the TetR expression reached saturation at doxycycline 3 µg/ml. 
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Figure3.24 TetR::mCherry expression in the NR and NF. 
(A) NR. (B) NF. NR was induced by doxycycline concentration 0, 2, 4, 4.5, 5, 5.5, 6, 6.5, 7 and 
10 µg/ml. NF strain was induced by doxycycline concentration 0, 0.5, 1, 1.5 2, 2.5, 3, 4, 5 and 6 
µg/ml. Data shown here was average of 3 replicates. Error bar refers to the SD of the 3 
replicates’ mean value. 
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3.8.2 Two-color NRpump, NRpump mutant, NFpump and NFpump mutant gene circuits 
and their TetR expression 
In order to monitor TetR expression in pump and pump mutant strains, 2-color pump 
strains were also induced by the same set of doxycycline concentration used for their single 
color counterparts, and their TetR expression was measured by flow cytometry. Same as NR 
strain, NRpump and NRpump-mutant strains all showed similar TetR expression level across 
the entire doxycycline concentrations. However, all the pump strains showed lower TetR 
expression than NR did (Figure 3.25 A). Among the three pump strains, NRpump-312 had 
higher TetR expression than the other two, which had the same TetR expression level (Figure 
3.25 A). As expressed for NF, NFpump and NFpump-mutant strains all showed increased TetR 
expression with increasing doxycycline concentration. However, all the pump strains had lower 
TetR expression compared to NF at every doxycycline concentration above 0.5 µg/ml.  Among 
the four NF series strains, NFpump had the lowest TetR expression; the two NFpump-mutants 
were in the middle, while NF had the highest TetR expression level. These results clearly 
indicated that pump strains had lower TetR expression than non-pump strains in both NR and 
NF, no matter if the pump was functional or not. The error bars indicated clone depended 
variation of TetR expression. According to the mathematical simulation developed by my 
collaborator, the TetR expression in NRpump and NRpump mutant strains were expected to be 
on the same level. Same applied to NF series strains. However, I noticed that although NRpump 
and NRpump-312 showed the same TerR expression level, NRpump-558 had a slightly higher 
level of expression. Besides, NFpump mutant strains both showed higher tetR expression than 
NFpump did. To my knowledge, the difference is highly likely due to clone variability, because 
strong clone dependent variation of TetR expression was observed in all the pump strains (in 
the figure we only showed 3 most representative replicates for each strain) (Figure 3.25 C and 
D). However, regardless of the variability of different clones in terms of TetR expression, all the 
pump clones showed lower TetR expression than the non-pump clones, which confirmed my 
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hypothesis that reduced TetR expression contributed to the dose-response change in pumps 
strains by reducing TetR repression on PDR5 transcription and therefore increased their 
sensitivity to doxycycline.  
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Figure 3.25 TetR::mCherry expression in all the NR related and NF related strains. 
(A) NR, NRpump and NRpump-mutant. (B) NF, NFpump and NFpump-mutant. (C) mCherry 
expression level in different NR series clones at no doxycycline environment. (D) mCherry 
expression level in different NF series clones at the maximum doxycycline concentration (6 
µg/ml). NR was induced by doxycycline concentration 0, 2, 4, 4.5, 5, 5.5, 6, 6.5, 7 and 10 µg/ml. 
NRpump and NRpump-mutant strains were induced by doxycycline concentration 0, 2, 4, 5, 6, 
7, 8, 9, 10 and 15 µg/ml. NF, NFpump and NFpump-mutant strain was induced by doxycycline 
1 1.5 2 2.5
NRpump-558
NRpump-312
NRpump
NR
mCherry (dox 0 µg/ml) 
0.5 1 1.5 2
NFpump-558
NFpump-312
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concentration 0, 0.5, 1, 1.5 2, 2.5, 3, 4, 5 and 6 µg/ml. Data shown in (A) and (B) was average 
of 3 replicates. Error bar refers to the SD of the 3 replicates’ mean value. 
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3.8.3 Endogenous Pdr5 expression does not affect dose-response results. 
Because endogenous Pdr5 was knocked out in all the pump strains, but not in NR and 
NF strains, I suspected that endogenous Pdr5 would affect the dose-response behavior of NR 
and NF strains by removing intracellular doxycycline. If this happened, the dose-response 
curves for NR and NF were not comparable to their pump counterparts. In order to test this 
hypothesis, I knocked out endogenous Pdr5 in the NR strain and characterized its dose-
response the same way I did for NR strain with endogenous Pdr5. Then the dose-response 
curves for the two NR strains were compared. The results showed that both NR strains 
exhibited sigmoidal dose-response curves, and the two dose-responses were indistinguishable 
(Figure 3.26). CV dose-responses for both NR strains were similar; they were low at both low 
and high doxycycline concentration and peaked at the same intermediate concentration (4.5 
µg/ml). The higher noise in NR (PDR5 KO) strain at low doxycycline concentration was probably 
background noise. Therefore, it is safe to conclude that endogenous Pdr5 expression did not 
affect the shape of dose-response curve for NR strain, which might be due to its extremely low 
level of expression in the cells, and can be neglected. Although the same experiment was not 
performed for NF strain, since endogenous Pdr5 did not change the dose-response curve for 
NR strain, it should not change it in NF strain either.  
 
3.8.4 The two-color NF strain is more sensitive to doxycycline than the single color NF.  
In my experimental data, I also noticed an interesting phenomenon. Although both 2-
color and single color NF strains showed linear dose-response curve in certain doxycycline 
concentration range, the dose-response mean curve of 2-color NF has steeper slope compared 
to that of single color NF, meaning that the 2-color NF was more sensitive to doxycycline than 
NF and reached saturation at lower doxycycline concentration (Figure 3.27 A and B). A related 
observation was made in earlier research 29. This might be due to the fusion of mCherry and 
TetR, which have weakened TetR’s repression of target gene transcription.  
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3.8.5 Correlation between TetR and target gene expression in NF and NFpump strains 
In NF gene circuits, the regulator, TetR, and the target gene, yEGFP::ZeoR, were 
constructed in symmetric positions, which meant that the expression of these two genes will 
correlate with each other. Previous research has shown the correlation 29. Since the expression 
of yEGFP::ZeoR increases with the increase of inducer concentration, in a linear manner, TetR 
expression was expected to show the same dose-response curve. In order to test the 
hypothesis, the 2-color NF strain was induced with the same set of doxycycline concentration 
used for single color NF induction. As a result, TetR and yEGFP::ZeoR expression had the 
exactly the same dose-response curves, which overlapped (Figure 3.28 A). Similarly, NFpump 
was expected to show the same correlation between TetR and PDR5::GFP expression, 
because the replacement of yEGFP::ZeoR by PDR5::GFP in NFpump gene circuit did not 
change its topological structure. In order to test this hypothesis, 2-color NFpump strain was 
induced by the same set of doxycycline concentrations used for single color NFpump strain 
induction. However, the results were not quite as expected. PDR5 expression showed higher 
sensitivity to doxycycline compared to TetR expression (Figure 3.28 B). The results indicated 
the existence of certain factors that changed the topological structure of NF network.  
 
 
 
 
 
 
 
 
 
 
87 
 
A B 
  
 
Figure 3.26 yEGFP expression in NR and NR (PDR5 knockout) strains. 
(A) Mean does-response. (B) CV dose-response. Both NR strains were induced by doxycycline 
concentration 0, 2, 4, 4.5, 5, 5.5, 6, 6.5, 7 and 10 µg/ml. Data shown here was average of 3 
replicates for each strain. Error bar refers to the SD of the 3 replicates’ mean value. 
 
 
 
 
 
 
 
88 
 
 
Figure 3.27 yEGFP expression in NF and 2-color NF strains. 
Both NF strains were induced by doxycycline concentration 0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5 and 6 
µg/ml. Data shown here was average of 3 replicates for each strain. Error bar refers to the SD of 
the 3 replicates’ mean value. 
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Figure 3.28 Correlation between TeR and target gene expression in NF and NFpump 
strains. 
 (A) TetR and yEGFP::ZeoR expression in NF. (B) TetR and PDR5::GFP expression in 
NFpump.  Both NF strains were induced by doxycycline concentration 0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 
5 and 6 µg/ml. Data shown here was average of 3 replicates for each strain. Error bar refers to 
the SD of the 3 replicates’ mean value. 
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3.9 Conclusion and discussion 
Based on previously characterized inducible synthetic gene circuits in Saccharomyces 
cerevasiae 29, NR and NF, I studied the functional effect of introducing a protein pump into these 
networks, by creating two relevant gene circuits, NRpump and NFpump. I found that Pdr5, a 
multidrug resistance pump, when placed under the control of NR and NF changed the inducer 
sensitivity of the two gene circuits. NRpump became more inducer-sensitive than NR at low 
doxycycline concentration, but less sensitive at high concentration (Figure 3.18 A). On the other 
hand, NFpump became more sensitive to doxycycline than NF at all doxycycline concentrations 
before saturation (Figure 3.20 A). These observations were contradictory to my expectation that 
both strains (NRpump and NFpump) should be less inducer-sensitive than their non-pump 
counterparts, considering that Pdr5 can exclude tetracycline family molecules from the cell and 
thereby decrease their intracellular concentration 143, 146, 147. These results implied the existence 
of an opposing force that increases inducer sensitivity in NRpump and NFpump. In order to 
uncover the unknown mechanism, we turned to computational modeling. Addition of the efflux 
pumping term to NR in our stochastic simulations was able to reproduce the mean dose-
response for NRpump at high doxycycline concentration, but failed at low concentration. 
Stochastic simulations were performed by my collaborator, Daniel Charlebois. Based on his 
simulations and parameter sensitivity analysis, I found that when synthesis rate of TetR was 
reduced, the simulations were able to reproduce the entire dose-response shift as I observed in 
the experiment (Figure 3.5 A). The same parameter settings applied to NFpump simulation was 
able to reproduce our experimental result as well (Figure 3.10 A). Therefore, I identified two 
potential mechanisms that contributed in opposite manner to the change of NRpump and 
NFpump dose-responses. In order to confirm the effect of the efflux pumping function of Pdr5 to 
the change of dose-response in pump strains in the experiment, I created NRpump and 
NFpump strains bearing PDR5 mutants with compromised efflux pumping function. The dose-
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responses of such pump mutant strains were intermediates between those of pump strains and 
non-pump strains. For example, the dose-response mean of NRpump mutants were similar to 
NR at high doxycycline concentration, but the same as NRpump at low doxycycline 
concentration (Figure 3.18 A); the mean dose-response of NFpump mutants restored linearity 
as exhibited by NF, but maintained high sensitivity to doxycycline at low to intermediate 
concentration as NFpump did (Figure 3.20 A). These results showed that the efflux pumping 
function of Pdr5 was responsible for the decreased sensitivity to doxycycline for NRpump at 
high doxycycline concentration, decreased sensitivity for NFpump at low and intermediate 
doxycycline concentration, and linearity loss in NFpump. Next, to confirm the computationally 
predicted role of TetR levels, I measured TetR expression in all the NR and NF series strains by 
fusing mCherry to TetR. The experimental measurements showed that TetR had lower 
expression level in all the pump strains (whether or not Pdr5 is functional) compared to NR and 
NF strains respectively, which confirmed my hypothesis. Lower TetR level in pump strains 
reduced the repression of PDR5 transcription, therefore, increased Pdr5 expression.  
Now we are able to explain the dose-response differences between pump strains and their non-
pump counterparts with the two opposing forces.  
The mechanism for reduced TetR expression in pump strains is still unclear and needs 
further investigation. Although TetR expression was reduced in all the pump strains, it was not 
caused by Pdr5 protein properties by the fact that TetR level remained the same during the 
entire dose-response in NR series strains. It is highly possible that the integration of the PDR5 
gene upstream of the TetR promoter impaired TetR transcription. This occurred in the pump 
stains but not non-pump strains because the PDR5 gene is over 5 kb while the ZeoR gene (in 
NR and NF) is around 1 kb. Another possibility is that the epigenetic modification (for example, 
methylation) of PDR5 affected the downstream transcription factor binding to TetR’s promoter. 
The assumption of impaired TetR transcription is supported by the unbalanced expression of 
TetR and PDR5-mutant in NFpump mutant strains (Figure 3.28 B).  
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I have proven that Pdr5 protein did not affect TetR expression. However, the expression 
of endogenous Pdr5 in NR and NF strains was still a concern for its influence on their dose-
response curve, because Pdr5 was knocked out in all the pump strains (including single color 
and 2-color), but not in NR and NF strains. In order to test that, Pdr5 was knocked out in NR 
strain, and we found that the Pdr5 knockout NR strain showed the same dose-response curve 
as normal NR strain did (Figure 3.27).  
Although reduced TetR expression affected the dose-response of all the pump strains, 
by comparing the dose-response difference between functional and non-functional pump 
strains, we can still see the changes caused by the efflux pumping function of Pdr5, which 
decreased the sensitivity to inducer.  
In my experimental data, I also noticed an interesting phenomenon. The dose-response 
mean curve of 2-color NF had steeper slope compared to single color NF, meaning that the 2-
color NF was more sensitive to doxycycline than NF and reached saturation at lower 
doxycycline concentration (Figure 3.28 A and B). Similar observations were made earlier 29. 
This might be due to the fusion of mCherry to TetR, which might have weakened TetR’s 
inhibition function.  
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Chapter 4 Effect of protein pump on Positive Feedback (PF) gene 
circuit and dose-respone memory change 
 
4.1 Introduction 
Multidrug resistance is a universal phenomenon that has been observed from 
the simplest microorganisms to the most advanced cell types. A number of 
mechanisms of multidrug resistance have been discovered, such as active exclusion 
of toxic molecules, which plays the most important role in protecting cells from 
adverse environment. In Saccharomyces cerevisiae, a complex regulatory network 
has evolved, in which Pdr5p plays a major role of pumping out toxic molecules. The 
PDR5 gene is naturally regulated by PDR1 and PDR3, both of which are transcription 
factors. Toxic substrates activate PDR1 expression, which then binds to the promoter 
of both PDR3 and PDR5 and starts their transcription. Pdr3 is also able to bind to its 
own promoter and the promoter of PDR5 and help transcribe the efflux pump protein. 
Therefore, PDR5 is regulated by a positive feedback network in the natural system. 
So, why did a positive feedback regulatory network evolve? Does the positive 
feedback regulatory network confer advantage for yeast cells to survive compared to 
other regulatory systems? If this is true, in what environment does positive feedback 
network give this advantage? In order to answer these questions, it will be worth 
trying to use the negative regulation (NR), negative feedback (NF), and positive 
feedback (PF) synthetic gene circuits to regulate the PDR5 gene, and compare the 
growth rate of cells carrying these gene circuits in different environments. For that 
purpose, the dose-response of PF controlling PDR5 gene needs to be studied. 
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In the previous chapter, PDR5 introduced into NR and NF gene circuits was 
discovered to change their dose response behavior by both efflux pumping activity 
and its influence on intracellular TetR concentration. Besides NR and NF, another 
gene circuit, Positive Feedback (PF) was also constructed and studied in our 
laboratory before. The PF gene circuit had a different dose-response pattern than 
either NR or NF gene circuits, showing bimodality. Since Pdr5 had been proved to 
pump out the intracellular inducer, doxycycline, it introduced negative feedback loops 
into the NR and NF regulatory networks. Therefore, I wanted to find out if Pdr5 
introduced into the PF gene circuit would change its behavior and if so, how it would 
change it. Inconstant to NR and NF, there are two stable steady states in PF cells, 
giving rise to two subpopulations and cells that switch from one to another. Previous 
research has identified the growth rate and cellular memory of these two 
subpopulations. The introduction of PDR5 will be highly likely to change these, and it 
will be interesting to find out now. 
 
4.2 PF gene circuit and characterization of its dose response 
Similar to the NR and NF gene circuits, the positive feedback (PF) gene circuit 
has two parts, the target gene (reporter) and the regulator. The target gene was the 
gene fusion ZeoR::yEGFP under the control of a modified CYC1 promoter, which 
bears two TetO sites. The reporter was the rtTA gene under the control of the same 
modified CYC1 promoter. rtTA is a transactivator that is able to bind to TetO sites 
only when bound by tetracycline compounds, such as doxycycline and ATc. In the 
presence of galactose and tetracycline, rtTA expressed at basal level could bind to 
tetracycyline, and this complex bound to TetO sites on the promoters driving both the 
reporter and the regulator, could activate the transcription of both yEGFP::ZeoR and 
95 
 
rtTA forming a positive feedback loop. The PFpump gene circuit shared most parts 
with PF, the only difference being that the yEGFP::ZeoR fusion in PF was replaced 
by PDR5::GFP gene in PFpump (Figure 4.1).  
 
A B 
  
 
Figure 4.1 Regulation scheme for Positive Feedback (PF) and Positive Feedback pump 
(PFpump mutant) gene circuits. 
 (A) PF. (B) PFpump.  
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Figure 4.2 Histograms of PF dose-response. 
The PF gene circuit was induced at 12 doxycycline concentrations, 0, 0.02, 0.04, 0.05, 0.06, 
0.08, 0.1, 0.15, 0.25, 0.5, 0.75 and 1 µg/ml; the histograms of yEGFP::ZeoR expression at each 
doxycycline concentration are shown. In each sample, cell culture was started with 0.5 x 106 
cells/ml, and every 12 hours, cell density was measured by Nexcelom, and a small amount of 
cell culture was inoculated into fresh medium aiming to start new culture with the cell density of 
0.5 x 106 cells/ml. 
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First, PF cells were induced with 12 different doxycycline concentrations, and flow 
cytometry was used to measure yEGFP::ZeoR expression in individual cells. At doxycycline 
concentrations 0 and 0.02 µg/ml, cells in the whole population showed minimal level of 
yEGFP::ZeoR expression. Starting at a doxycycline concentration of 0.04 µg/ml, a group of high 
yEGFP::ZeoR expressers appeared, making the fluorescence intensity histogram bimodal. With 
increased doxycycline concentration, the high peak grew while the low peak shrank. At a 
doxycycline concentration of 0.08 µg/ml, the majority of cells in the population already 
expressed a high level of yEGFP::ZeoR. When doxycycline concentration reached 0.5 µg/ml, 
the low peak almost disappeared and the histogram remained the same with further increase of 
doxycycline concentration until it reached 1 µg/ml (Figure 4.2).  
Then the mean for the cell population at each doxycycline concentration was calculated, 
and plotted against doxycycline concentration. It had a sharp rise starting from doxycycline 
concentration 0.04 µg/ml until doxycycline reached 0.1 µg/ml, after which the increase of the 
mean slowed down compared to the beginning. The mean reached saturation when doxycycline 
concentration reached 0.5 µg/ml, which agreed well with the histogram (Figure 4.3 A). Next, the 
CV was calculated. It started low, and showed a very sharp increase starting at doxycycline 
concentration 0.04 µg/ml and reached a high peak at doxycycline concentration 0.08 µg/ml, 
where the bimodal distribution had two peaks of similar height. After reaching the peak, the CV 
showed a sharp decrease until doxycycline concentration reached 0.25 µg/ml, and then it 
flattened down at doxycycline concentration of 1 µg/ml.  
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Figure 4.3 PF mean and CV dose-responses. 
 (A) Mean dose-response. (B) CV dose-response. Cells carrying PF gene circuit was induced 
by 12 doxycycline concentrations: 0, 0.02, 0.04, 0.05, 0.06, 0.08, 0.1, 0.15, 0.25, 0.5, 0.75 and 1 
µg/ml. The plots show the average of 3 replicates. Error bars indicate the SD of the 3 replicates’ 
mean value. 
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4.3 PFpump gene circuit and characterization of its dose-response 
After obtaining the dose-response for the PF gene circuit, I wondered how the PDR5 
gene would change its dose-response. Therefore, the dose-response for the PFpump gene 
circuit was characterized with the same experimental procedure as for the PF gene circuit. In no 
doxycycline environment, all the cells in the population expressed uniformly low level of 
PDR5::GFP. When doxycycline concentration was increased to 0.02 µg/ml, a high PDR5::GFP 
expresser peak appeared, although the low expressers were the majority of the population. 
When doxycycline concentration reached 0.04 µg/ml, low expressers and high expressers 
showed almost equal peaks, meaning that the number of low expressers roughly equaled the 
number of high expressers. With further increase of doxycycline concentration, more cells 
switched to the high PDR5::GFP expression level from the low level, until it reached the 
concentration of 0.25 µg/ml, where all cells in the population became high expressers, and the 
histogram did not change with further increase of doxycycline (Figure 4.4).  
Next, the mean and CV were calculated at each doxycycline concentration. From 
doxycycline 0.02 µg/ml to 0.1 µg/ml, the dose-response curve showed a steep rise, and then it 
slowed down with further increase of doxycycline concentration. The curve reached saturation 
around a doxycycline concentration of 0.25 µg/ml (Figure 4.5 A). The PDR5::GFP expression 
noise or CV peaked at doxycycline concentration 0.04 µg/ml, which corresponded well to the 
almost equal peaks in the reporter expression histogram with bimodal distribution.  The CV was 
low at low and high doxycycline concentrations because all or majority of cells expressed either 
low or high PDR5::GFP in either case (Figure 4.5 B). 
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Figure 4.4 Histograms of PFpump dose-response. 
The PF gene circuit was induced at 10 doxycycline concentrations, 0, 0.02, 0.04, 0.05, 0.06, 
0.08, 0.1, 0.15, 0.25 and 0.5 µg/ml; the histograms of PDR5::GFP expression at each 
doxycycline concentration were shown. In each sample, cell culture was started with 0.5 x 106 
cells/ml, and every 12 hours, cell density was measured by Nexcelom, a small amount of cell 
culture was inoculated into fresh medium aiming to start new culture with the cell density of 0.5 
x 106 cells/ml. 
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Figure 4.5 PFpump mean and CV dose-response. 
 (A) Mean dose-response. (B) CV dose-response. Cells carrying PFpump gene circuit were 
induced by 10 doxycycline concentrations: 0, 0.02, 0.04, 0.05, 0.06, 0.08, 0.1, 0.15, 0.25 and 
0.5  µg/ml. The plots show the average of 3 replicates. The plots show the average of 3 
replicates. Error bars indicate the SD of the 3 replicates’ mean value. 
A B 
  
Figure 4.6 PF and PFpump mean and CV dose-response. 
 (A) Mean dose-responses. (B) CV dose-responses. The plots show the average of 3 replicates 
for each strain. Error bar indicate the SD of the 3 replicates’ mean value. 
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Although the dose-response behaviors of PF and PFpump were similar, they had 
differences as well. The mean dose-response of PFpump was more sensitive to doxycycline 
compared to PF (Figure 4.6 A), which was consistent with the results from NR-NRpump and 
NF-NFpump comparison. The CV peak of PFpump appeared earlier than for PF, which might be 
due to the higher sensitivity of PFpump to doxycycline (Figure 4.6 B). The CV peak of PF was 
much higher than that of PFpump, probably because the GFP fluorescence intensity was higher 
in PF (Figure 4.6 B), or because PFpump incorporated negative feedback that lowers noise.  
Comparing the histograms of PF and PFpump, I found that PF and PFpump differ at 
identical doxycycline concentration (Figure 4.7). For example, at doxycycline concentration 0.05 
µg/ml, PFpump had higher percentage of high expressers compared to PF. First, I thought that 
the pump actively excludes doxycycline from the cells, so it would take higher doxycycline 
concentration for PFpump to reach the same percentage of high expressers as PF does (Figure 
4.7). However, the experimental observation was quite contradictory. In order to explain the 
discrepancy, we decided to measure the growth rate and cellular memory of both low and high 
expressers in PFpump. Cellular memory was defined by the average time for each individual 
cell to stay in one gene expression state. Previous work showed that PF cells switch between 
the two subpopulations in the histogram. The cell growth rate and cellular memory was 
calculated for each subpopulation, and differed 81. Since PFpump had bimodal expression as 
well, I wanted to determine its growth rate and cellular memory.  
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Figure 4.7 Histograms of target gene expression in PF and PFpump. 
(A) PF cells induced in doxycycline. (B) PFpump cells induced in doxycycline. PF cells were 
induced by doxycycline concentrations 0, 0.02, 0.04, 0.05, 0.06, 0.08, 0.1, 0.15, 0.25, 0.5, 0.75 
and 1 µg/ml. PFpump cells were induced by 10 doxycycline concentrations: 0, 0.02, 0.04, 0.05, 
0.06, 0.08, 0.1, 0.15, 0.25 and 0.5 µg/ml. 
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4.4 Measurement of PFpump growth rate 
First of all, I measured the growth rate for the two PFpump subpopulations. In order to 
do so, I induced the PFpump strain in SD medium with a doxycycline concentration of 0.05 
µg/ml until gene expression became stable. Then the cell culture was sorted into high 
expressers and low expressers, the threshold used for the separation was the valley point on 
the histogram (Figure 4.4 C). Cell densities were measured every 2 hours for 24 hours and then 
every 12 hours for 96 hours for each of the subpopulations. The growth rate of PFpump cells 
induced at the same doxycycline concentration without cell sorting (mixed population) was 
measured as well. At the same time, PDR::GFP expression in each subpopulation was 
measured every 12 hours. Because the two subpopulations switch to each other, they should 
return to the original histogram before cell sorting. That was where the experiment ended. Data 
gathered through the experiments was used for computational estimation of growth rate. The 
growth rate for the two subpopulations and the mixed population were all decreasing with 
increasing doxycycline concentrations. However, the growth rate of high expressers decreased 
the most, while the growth rate of low expressers only showed slight decrease. The growth rate 
of the mixed population was intermediate, closer to the low expresser growth rate in low 
doxycycline concentration, but closer to high expresser growth rate once doxycycline 
concentration reached 0.05 µg/ml and beyond (Figure 4.8).  
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Figure 4.8 Growth rate properties of PFpump. 
Computational estimation of the growth rate for low and high subpopulations. Parameters were 
obtained from experiments. Low and high subpopulations were separated by cell sorting, and 
grown in separate tubes containing SD mediums. Growth rate of cells in each tube and the 
whole cell population were measured every 2 hours until the reporter expression histogram 
recovered to the same as before sorting. The growth rate of the whole cell population was 
shown here, the growth rate for sorted cells were used to estimate the low and high expressors’ 
growth rate.   
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Figure 4.9 Cellular memories of the two subpopulations of PFpump and PF. 
(A) PFpump cellular memory. (B) PF cellular memory 81. The black dotted line in both figures 
indicated where the high expresser and low expresser plots were equal in the histogram.  
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4.5 Comparison of memory between PF and PFpump strains 
Next, I investigated the cellular memory of PFpump. Computational estimation showed 
that the memory for the low expressers was 10.9 hours at doxycycline concentration 0.05 µg/ml, 
while that for the high expresser was 6.9 hours (figure 4.9). The memory of the low expressers 
remained relatively constant over the entire doxycycline concentration range, but the memory of 
high expressers increased from doxycycline concentration 0 to 0.1 µg/ml an remained constant 
afterwards (Figure 4.9). After obtaining the cellular memory of PFpump, we decided to compare 
it with PF and see if the efflux pump, Pdr5, would cause memory change. With data from 
previous work, I found that the cellular memory of low expressers was 16 hours at ATc 
concentration 10 ng/ml, at which the two subpopulations showed almost equal number of cells. 
However, the memory for high expressers was extremely high, 283 hours, at the same ATc 
concentration. Therefore, although low expressers and high expressers were in the same 
amount of cells in the population, the difference between their memories differed tremendously 
in PF and PFpump.  
 
4.6 Conclusion and discussion 
Here, I characterized the dose-response for PFpump for the first time. Although the 
dose-response of PF had been measured, it was induced by ATc. Since ATc is sensitive to light, 
and is not as stable as doxycycline, I re-characterized the PF dose response with doxycycline 
as inducer.  Both PF and PFpump showed bimodal distribution at intermediate doxycycline 
concentrations, which suggested that the negative feedback loop introduced by Pdr5 did not 
interfere with a key fracture from positive feedback loop, bimodality. It is interesting to note that 
although negative feedback was shown to reduce the variability of steady states, PFpump still 
showed bimodality. Compared to the dose-response curves of NR and NF gene circuits, the 
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doxycycline concentrations used for PF and PFpump were much lower, indicating higher 
sensitivity of PF gene circuits. The PF and PFpump mean and CV dose-responses were similar. 
The mean dose-response increased sharply between low and intermediate doxycycline 
concentration, and then slowed down until the curves reached saturation at high doxycycline 
concentration, which was 0.25 µg/ml. Both CVs both had a single peak at intermediate 
doxycycline concentration, indicating diverse expression of target genes in individual cells in the 
population. However, PFpump cells were more sensitive to doxycycline than PF cells, proved by 
the fact that PFpump had higher mean than PF at the same doxycycline concentration (Figure 
4.6).  When I looked at the histograms for both strains, I found that higher percentage of 
PFpump cells became high expresser than PF cells at the same doxycycline concentration 
(Figure 4.7). This result was completely opposite to my expectation, because Pdr5 was an efflux 
pump, and it has been shown to pump out doxycycline 143, 146, 147. Therefore, Pdr5 was expected 
to reduce intracellular doxycycline concentration and, as a result, PFpump cells were expected 
to have less high expresser than PF at the same doxycycline concentration. This contradictory 
discovery led us to think about previous work published in our lab about growth rate and cellular 
memory of the two subpopulations in PF strain. Growth rate referred to the cell growth rate, 
cellular memory was the average time an individual cell stayed in one stable steady state. The 
research showed that the two subpopulations grew at different rates, and their cellular memory 
differed tremendously. Therefore, I wondered if Pdr5 changed either the growth rate or cellular 
memory of the two subpopulations, or both. In order to answer this question, I measured the 
growth rate and cellular memory of the two subpopulations and mixed populations in PFpump. 
All of the three populations growth rate decreased with increasing of doxycycline concentration, 
which suggested that doxycycline caused the reduction of growth rate of PFpump cells. Low 
expressers only showed a slightly decrease of growth rate with increasing doxycycline 
concentration, which was the lowest reduction among the three populations. On the contrary, 
high expressers showed the highest reduction, which suggested that the expression of 
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PDR5::GFP reduced the cells’ growth rate. Since the growth rate of PF cells had been 
characterized in our lab before, I wondered if Pdr5 changed the growth rate of cells bearing PF 
gene circuits. In order to test that, I compared my data from PFpump growth rate with previous 
data of PF growth rate. Because previous work on PF growth rate was done with ATc as 
inducer, here I needed to find the corresponding doxycycline concentration for ATc 
concentration used in previous work. In order to do that, I compared the histogram of PF 
induced by both ATc and doxycycline. When the PF cells were induced to show two equal 
peaks on the histogram, 10 ng/ml ATc or 0.08 µg/ml doxycycline was required (Figure 4.6 C and 
D). Therefore, we considered 10 ng/ml ATc and 0.08 µg/ml doxycycline to be equivalent. At an 
ATC concentration of 10 ng/ml, the overall growth rate of PF cells was reduced to 80% of the 
maximum growth rate, meaning the growth rate of cells without any inducer. More dramatically, 
the growth rate of high expressers was reduced to 70% of the maximum growth rate. 
Comparably, at doxycycline 0.08 µg/ml, the overall growth rate was above 90% of the maximum 
growth rate, while the growth rate for high expressers showed slightly slower than the overall 
growth rate (Figure 4.10 A and B). In summary, introduction of Pdr5 partially recovered the 
growth rate in PF high expressers. There are several possible explanations. According to 
previous research, the growth rate of PF cells was 0.22 division per hour in no induction 
condition, while the growth rate of PFpump was 0.32 division per hour in my study, and the 
absolute value of growth rate reduction to ATC 10 ng/ml or doxycycline 0.08 µg/ml for the two 
strains were both 0.015 division per hour. Therefore, it is possible that the reduction of growth 
rate was not relevant to what gene was expressing, meaning that the protein expression itself 
would reduce growth rate because it took more resources and utilize more energy in the cells.  
Second possibility was relevant to the efflux pumping activity of Pdr5. It has been discovered 
that yeast cells with endogenous Pdr5 knockout showed decreased growth rate compared to 
cells with normal native Pdr5 expression. The reason was that yeast cells generated metabolic 
wastes during their growth, and Pdr5 was able to pump out those toxic molecules. Thus, it was 
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possible that the expression of Pdr5 in PFpump cells reduced intracellular toxic molecules and 
gave PFpump cells an advantage for growth.  
After obtaining the growth rate for the two subpopulations of PFpump cells, cellular 
memory of the two subpopulations were also calculated, because growth rate and cellular 
memory were the two factors that contributed to the bimodal histograms of PF and PFpump 
cells. Previous research had identified the cellular memory for the two subpopulations of PF 
cells. Here I measured the cellular memory of PFpump cells and discovered that the memory for 
low expressers was close to that of PF cells. However, the memory for high expressers in 
PFpump cells was much shorter compared to their counterparts in PF cells. One possible 
explanation was the efflux pumping activity of Pdr5. Since Pdr5 was able to pump out 
doxycycline, which was supposed to lower intracellular doxycycline concentration and therefore 
facilitated the back switch of high expressers to low expressers. Second explanation might be 
that Pdr5 affected the concentration of rtTA. In Chapter 3, I discovered the correlation that the 
presence of Pdr5 lowered tetR concentration. rtTA used here in PF and PFpump cells was a 
fusion protein composed of tetR and VP16 transactivation domain, so it is possible that Pdr5 still 
affects the concentration rtTA.   
 
4.7 Future direction 
First of all, since Pdr5 was shown to lower TetR concentration in NR-NRpump and NF-
NFpump dose-response comparison, it will be interesting to know if Pdr5 also affected rtTA 
concentration in PFpump cells, because rtTA is tetR protein fused with the transactivation 
domain of VP16. Construction of PF and PFpump strains with fluorescence labeled rtTA will be 
necessary for the investigation. If Pdr5 was proved to affect rtTA concentration, immune-
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precipitation assay will be done to detect if there is direct interaction between Pdr5 and rtTA. 
Second, stochastic simulation will be done to reproduce experimental dose-response data.  
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Figure 4.10 Growth rate comparisons between PF and PFpump. 
(A) Growth rate of PF strain. Fitness overall refers to the PF population without cell sorting, 
mixture of low and high expressers. Fitness low refers to the growth rate of low expressers. (C) 
Fluorescence intensity histograms of PF induced by ATc. (D) Fluorescence intensity histograms 
of PF induced by doxycycline.  
PF histogram 
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Chapter 5 Molecular evolution of NRpump, NFpump and PFpump 
strains 
 
5.1 Introduction  
PDR5 encodes a multidrug resistance protein, which functions as an efflux pump on the 
cell membrane in Saccharomyces cerevisiae. The natural PDR5 gene transcription is under the 
control of Pdr1 and Pdr3 proteins. PDR1 gene encodes a transcription factor that binds to the 
promoter of both PDR3 and PDR5 genes, and initiates their transcription after the binding. 
PDR3 also encodes a transcription factor which is able to activate the transcription of itself and 
PDR5 gene. Thus, Pdr3 forms a positive feedback loop to regulate PDR5 transcription in the 
natural system. The presence of toxic molecules or drugs activates the expression of PDR1, 
which consequently leads to the transcription of both PDR3 and PDR5; more PDR3 expression 
will amplify the expression level of itself and PDR5, which form a positive feedback network. 
Once toxic molecules are pumped out by the Pdr5 protein, PDR1 returns to the normal level and 
as a consequence reduces Pdr3 and Pdr5 in the cells. Since the dose-response of the three 
gene circuits controlling PDR5, NRpump, NFpump and PFpump have been characterized, and 
were very different (shown in the previous chapters), I wondered if the three gene circuits would 
have different protection for the cell population in adverse environment. The result might be able 
to explain the evolution and natural selection of positive feedback loop in the regulation of PDR5 
transcription.  
 
5.2 Pdr5 confers cells protection from fluconazole treatment 
It has been shown that Pdr5 can pump out fluconazole and confer protection to the cells 
by the fact that the ∆pdr5 strain was hypersensitive to fluconazole treatment 94. Here I wanted to 
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confirm that the PDR5::GFP fused protein expressed in the gene circuits used in my study was 
able to confer resistance to fluconazole treatment as well.  YPH500 and RFpump strains 
(Reference strain) were used for the test. YPH500 was the parental strain, on which all of the 
other strains were constructed based, by inserting specific synthetic gene circuits into its HIS3 
locus on the genome. Similarly, the RFpump strain was constructed by the integration of the 
RFpump gene circuit into the genome of the YPH500 strain. Similar to other pump gene circuits, 
the RFpump gene circuit also contains 2 parts, the regulator and the reporter. The regulator has 
a TetR gene under the control of wild type GAL1 promoter, while the reporter has PDR5::GFP 
fused gene under control of the same wild type GAL1 promoter (Figure 5.1). Therefore, no TetR 
binding sites were introduced in any of the promoter regions in RFpump gene circuit. As a 
result, PDR5::GFP will be expressed at a constant rate in the presence of galactose.  
Next, survival of YPH500 and RFpump strains in fluconazole environment was tested. 
Six different fluconazole concentrations were used (0 µg/ml, 2 µg/ml, 4 µg/ml, 6 µg/ml, 8 µg/ml 
and 10 µg/ml) to treat both strains, while no fluconazole cultures were used as negative control. 
All of the cell cultures were resuspended every 12 hours to maintain their growth in exponential 
phase. When the YPH500 strain was cultured in 0 µg/ml fluconazole environment, its growth 
curve remained linear on semi log scale, because the cells kept growing in exponential phase 
during the entire experiment (Figure 5.2 A). However, in the presence of fluconazole, the 
YPH500 strain grew at a rate slightly slower than in no fluconazole environment in the first 12 
hours, then the growth curve became flat, indicating a complete growth arrest (Figure 5.2 A). In 
contrast, the RFpump strain showed the same growth rate in all fluconazole concentrations and 
the negative control, indicated by the linear growth curves in all of the 6 conditions (Figure 5.2 
B). In conclusion, PDR5::GFP was able to confer cells complete resistance to fluconazole 
concentration up to 10 µg/ml.  
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Figure 5.1 Composition of RFpump gene circuit. 
In the PFpump gene circuit, both the TetR and the PDR5::GFP fusion gene were under control 
of the wild type Gal1 promoter, which was expressed constitutively in the presence of galactose. 
Therefore, RFpump expression was not doxycycline dependent. 
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Figure 5.2 YPH500 and RFpump growth rate in the fluconazole concentrations of 0 – 10 
µg/ml. 
(A)YPH500 strain. (B) RFpump strain. Both strains were treated with 6 fluconazole 
concentrations: 0, 2, 4, 6, 8 and 10 µg/ml. In each sample, cell culture was started with 0.5 x 106 
cells/ml, and every 12 hours, cell density was measured by Nexcelom, a small amount of cell 
culture based on the calculation was inoculated into fresh medium to start new culture with the 
cell density, 0.5 x 106 cells/ml. Cell count was plotted with the natural log as base.  
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5.3 NRpump and NFpump gene circuits evolved resistance to fluconazole 
treatment without induction 
PDR5::GFP expression in the RFpump gene circuit was able to protect cells from 
fluconazole treatment in the previous experiment. Next I asked if Pdr5 under the control of NR, 
NF and PF gene circuits would give cells different survival advantages in the fluconazole 
environment. I have shown that NRpump, NFpump and PFpump gene circuits showed different 
distribution of Pdr5 expression under induction as discovered in the prior two chapters. 
However, the first step was to know how each synthetic gene circuit survives in the fluconazole 
environment without induction. Therefore, NRpump, NFpump and PFpump strains were treated 
with the same set of fluconazole concentrations as it was used for YPH500 and RFpump 
strains, but no doxycycline was added into the cell culture, meaning that only basal level Pdr5 in 
the gene circuits was expressed. The results of the three strains were all similar to YPH500 
strain in the first 12 hours of fluconazole presence: the growth rate was slightly slowed down 
compared to no fluconazole cell culture (Figure 5.3). It has been found that fluconazole entered 
into the cells by diffusion, and it took at least 8 hours for the cells to respond (Data not shown). 
After the first 12 hours, the three strains showed different response patterns to fluconazole. 
Moreover, the three strains had different growth rates after 36 hours in fluconazole environment. 
The growth rate of NRpump first slowed down and became flat, suggesting the growth was 
completely ceased. Then the growth rate of the NRpump strain started to recover, and gradually 
went back to a level comparable to the cell culture in no fluconazole environment. This 
conclusion was supported by the fact that the growth rate curves of the 6 cell cultures became 
parallel after 48 hours (Figure 5.3 A). The curve of NFpump growth rate was similar to NRpump 
in that it first slowed down to flat after 24 hours culturing in fluconazole environment, and then 
recovered back to normal after 48 hours presence in fluconazole (including the no fluconazole 
control). Similar to NRpump cells, the growth rate of NFpump also recovered after a period of 
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fluconazole presence. However, differences remain.  Unlike NRpump cells that had the same 
growth rate curve at different fluconazole concentration, NFpump cells responded differently. 
NFpump responded to lower fluconazole concentration (2 µg/ml) slower than NRpump did, 
indicated by the data that the growth rate of NFpump cells went flat after 24 hour in the 
fluconazole treatment, while it only took NRpump cells 12 hours to stop growing (Figure 5.3 A 
and B). No significant difference was observed for the response to fluconazole concentration 
higher than 2 µg/ml between NFpump cells and NRpump cells. On the contrary, the growth rate 
of PFpump cells became flat after 12 hours in all fluconazole concentrations (except 0 µg/ml), 
and the growth rate remained extremely low during the entire time with treatment. 
Since the growth rates of NRpump and NFpump went back to normal after 48 hours 
presence in the fluconazole environment, I wondered if the recovery was caused by Pdr5 
expression from the synthetic gene circuits. In order to test that, I measured PDR::GFP 
expression in the NRpump and NFpump cells by flow cytometry. The histograms showed that 
48 hours after fluconazole treatment, Pdr5 was expressed at high level in every cell in the 
NRpump population at all the fluconazole concentrations, compared to basal expression of Pdr5 
in the no fluconazole treatment control group (Figure 5.4 A). The histograms for NFpump 
showed similar pattern. The only difference was that at a fluconazole concentration of 2 µg/ml, 
NFpump showed bimodal distribution in the histogram with most of the cells in the population 
expressing high level of Pdr5 while only a small fraction remained Pdr5 low expressers (Figure 
5.4 B). Since negative feedback loop has been proved to reduce gene expression noise, the 
bimodal distribution was highly likely due to two distinct subpopulations. This result suggested 
three possibilities for the fluconazole resistant cells. 1) The bimodal distribution was due to 
stochastic switching of cells. Even in the NF strains, there is a very small amount cells 
expressing high level of Pdr5, which could have taken over the whole cell population in the 
fluconazole treatment. 2) A single mutation might have occurred that made cells switch back 
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and forth in two Pdr5 expression states as PF and PFpump cells do. A mutation that weakened 
TetR function will lead to this stochastic switching. 3) The existence of a fluconazole resistant 
NFpump subpopulation without Pdr5 expression, which suggested the involvement of other 
factors in fluconazole resistance appeared in NFpump strains. 
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Figure 5.3 NRpump, NFpump and PFpump growth rate in the fluconazole concentrations 
of 0 – 10 µg/ml. 
(A) NRpump strain. (B) NFpump strain. (C) PFpump strain. All the three strains were treated 
with 6 fluconazole concentration: 0, 2, 4, 6, 8 and 10 µg/ml. In each sample, cell culture was 
started with 0.5 x 106 cells/ml, and every 12 hours, cell density was measured by Nexcelom, a 
small amount of cell culture based on the calculation was inoculated into fresh medium to start 
new culture with the cell density, 0.5 x 106 cells/ml. Cell growth rate was then calculated and 
plotted. Cell count was plotted with the natural log as base.  
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Figure 5.4 PDR5 expression histograms of NRpump and NFpump at 48th hour in the 
fluconazole concentrations of 0 – 10 µg/ml. 
(A) NRpump strain. (B) NFpump strain. Both strains were treated with 6 fluconazole 
concentration: 0, 2, 4, 6, 8 and 10 µg/ml. In each sample, cell culture was started with 0.5 x 106 
cells/ml, and every 12 hours, cell density was measured by Nexcelom, a small amount of cell 
culture based on the calculation was inoculated into fresh medium to start new culture with the 
cell density, 0.5 x 106 cells/ml. PDR5::GFP expression was measured by flow cytometry every 
24 hours. 
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Figure 5.5 PDR5 expression histograms of NRpump and NFpump after the fluconazole 
removal. 
(A) NRpump strain. (B) NFpump strain.  Both strains were first cultured in SD medium with a 
fluconazole concentration of 10 µg/ml until PDR5::GFP expression was confirmed from the gene 
circuits by flow cytometry. Then the NRpump and NFpump cells cultured in SD medium without 
fluconazole for 72 hours. In each sample, cell culture was started with 0.5 x 106 cells/ml, and 
every 12 hours, cell density was measured by Nexcelom, a small amount of cell culture based 
on the calculation was inoculated into fresh medium to start new culture with the cell density, 0.5 
x 106 cells/ml. PDR5::GFP expression was measured by flow cytometry every 24 hours. 
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It was unexpected to discover that PDR5::GFP from NRpump and NFpump gene circuits 
was expressed in the fluconazole environment in the absence of any tetracycline family inducer. 
Two possibilities existed. First,  could cause cells to switch from low Pdr5 expression status to 
high Pdr5 expression status without changing their genomes. The bimodal distribution of 
NFpump in a fluconazole concentration of 2 µg/ml confirmed existence of two sub-populations, 
so I wondered if these two subpopulations would switch to each other as PF and PFpump 
strains showed in the last chapter. Second possibility for Pdr5 expression from the NRpump and 
NFpump gene circuits was the breakdown of the two gene circuits. PDR5 was under the control 
of modified a GAL1 promoter in both NRpump and NFpump gene circuits, so that PDR5 
transcription was repressed by TetR unless tetracycline family molecules were present. If TetR 
lost its repression capacity by genetic mutation or the modified GAL1 promoter changed the 
sequence of TetO sites, which TetR protein binds, the transcription of PDR5::GFP would have 
no repression, and as a consequence, Pdr5 would be expressed in the absence of doxycycline. 
In order to test these two possibilities, both NRpump and NFpump strains were first treated with 
10 µg/ml fluconazole for 48 hours, and then they were switched to the no fluconazole 
environment and cultured in the same condition for 84 hours. As expected, the histograms of 
NRpump showed high PDR5::GFP expression after 48 hours (data not shown). Moreover, the 
histograms remained the same at every time point after fluconazole removal until the 84th hour 
(Figure 5.5 A). Similarly, the histograms of NFpump did not show significant change either after 
fluconazole removal. They only showed a small peak that was slightly lower than the original 
high Pdr5 expression peak. The new peak grew higher over time, but it was still a small fraction 
compared to the majority of the cells that expressed higher Pdr5 than the basal levl (Figure 5.5 
B). These results suggested that the expression of PDR5::GFP form NRpump and NFpump 
gene circuits were possibly due to the gene circuits’ breakdown. DNA sequence data is still 
needed for confirmation.  
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After identification of fluconazole response curves for NRpump and NFpump, I noticed 
that even cells treated with the lowest fluconazole concentration, 2 µg/ml, showed full 
resistance, which made me to wonder if lower fluconazole concentration would induce a 
different response, such as NFpump cells in a fluconazole concentration of 2 µg/ml (Figure 5.4). 
Therefore, a new set of fluconazole concentrations were used to treat NRpump and NFpump 
strains. For NRpump strain, fluconazole concentrations below 0.6 µg/ml did not cause 
distinguishable difference on its growth rate compared to cells growing in no fluconazole 
environment. NRpump cells treated with a fluconazole concentration of 0.8 µg/ml showed a 
reduced growth rate starting at the 48th hour after fluconazole presence, but their growth rates 
recovered back to normal level after 120 hours in the fluconazole treatment. The growth rate of 
NRpump cells growing in fluconazole concentrations of 1.0 µg/ml and 1.5 µg/ml both slowed 
down after 24 hours treatment, cells in the fluconazole concentration of 1.0 µg/ml recovered 
their growth rate after 60 hours in the treatment, while it took cells in the fluconazole 
concentration of 1.5 µg/ml additional 12 hours to recover its growth rate back to the normal level 
(Figure 5.6 A). The growth rate of NFpump cells did not show distinguishable difference up to 
fluconazole concentration 1.0 µg/ml. Cells in a fluconazole concentration of 1.5 µg/ml showed 
decreased growth rate after 60 hours in the fluconazole environment, which was similar to 
NRpump in a fluconazole concentration of 0.8 µg/ml. The reduced growth rate recovered back 
to normal after 84 hours in the treatment (Figure 5.6 B). The comparison between NRpump and 
NFpump suggested that NRpump cells had higher sensitivity to fluconazole than NFpump cells 
did, which might relate to their different basal expression. Because it has been shown that NF 
has higher basal reporter expression than NR does in the previous research in our lab, and this 
higher expression was able to confer significant difference in cells’ resistance to drug treatment.   
Besides measuring the growth rate of NRpump and NFpump cells in the new set of 
fluconazole concentrations (0 µg/ml to 1.5 µg/ml), I also measured their PDR5::GFP expression 
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at each fluconazole concentration from 48 hours to 120 hours in the fluconazole treatment. 
From the fluconazole concentrations 0 µg/ml to 0.6 µg/ml, all the NRpump cells in the 
population expressed at basal level Pdr5 at all the time points. However, from fluconazole 
concentrations 0.8 µg/ml to 1.5 µg/ml, the histograms showed bimodal distribution, indicating a 
fraction of cells in the population became Pdr5 high expressers. The fraction of high expressers 
increased with the increase of fluconazole concentrations (Figure 5.7). By contrast, cells treated 
with a fluconazole concentration of 1.5 µg/ml showed an increased fraction of low expressers in 
the histograms with time passing by (Figure 5.7.  This result suggested other resistance 
mechanism to fluconazole existed along with increased Pdr5 expression from the gene circuit in 
NRpump cells. 
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Figure 5.6 NRpump and NFpump Growth rate in the fluconazole concentrations of 0 – 1.5 
µg/ml. 
(A) NRpump strain. (B) NFpump strain.  Both strains were cultured in 7 different fluconazole 
concentrations: 0, 0.2, 0.4, 0.6, 0.8, 1 and 1.5 µg/ml. In each sample, cell culture was started 
with 0.5 x 106 cells/ml, and every 12 hours, cell density was measured by Nexcelom, a small 
amount of cell culture based on calculated was inoculated into fresh medium to start new culture 
with the cell density, 0.5 x 106 cells/ml. Cell growth rate was then calculated and plotted. 
PDR5::GFP expression was measured by flow cytometry every 24 hours. Cell count was plotted 
with the natural log as base.  
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Figure 5.7 NRpump histograms in fluconazole concentrations of 0 – 1.5 µg/ml. 
(A) 48 hours after the fluconazole treatment. (B) 72 hours after the fluconazole treatment. (C) 96 
hours after the fluconazole treatment. (D) 120 hours after the fluconazole treatment. NRpump 
cells were cultured in 7 different fluconazole concentrations: 0, 0.2, 0.4, 0.6, 0.8, 1 and 1.5 
µg/ml. In each sample, cell culture was started with 0.5 x 106 cells/ml, and every 12 hours, cell 
density was measured by Nexolum, a small amount of cell culture based on the calculation was 
inoculated into fresh medium to start new culture with the same cell density, 0.5 x 106 cells/ml. 
Cell growth rate was then calculated and plotted. PDR5::GFP expression was measured by flow 
cytometry every 24 hours. 
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PDR5:GFP expression was also measured in the new set of fluconazole concentration 
treatment in NFpump cells. From fluconazole concentrations 0 µg/ml to 0.8 µg/ml, the 
histograms only showed one peak composed of low Pdr5 expressers, indicating only basal Pdr5 
expression in the whole population. At a fluconazole concentration of 1 µg/ml, a small peak 
showed up in the high fluorescence intensity zone, indicating small fraction of cells expressing 
high level of Pdr5. When fluconazole concentration reached 1.5 µg/ml, the vast majority of cells 
became high Pdr5 expressers with only a very small percentage of cells remaining as low 
expressers. When the fluconazole dose-responses of NRpump and NFpump were compared, 
differences were revealed. For example, from fluconazole concentrations 1.0 µg/ml to 1.5 µg/ml, 
the gradually increased fraction of low expressers in NRpump cells did not show up in NFpump 
cells. Instead, NFpump cells jumped to entirely high Pdr5 expressers from the distribution with 
majority of low Pdr5 expressers. The results suggested a gap between fluconazole 
concentrations 1.0 µg/ml and 1.5 µg/ml that might be able to induce bimodal distribution in 
NFpump cells.  
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Figure 5.8 NFpump histograms in the fluconazole concentrations of 0 – 1.5 µg/ml.  
(A) 48 hours after the fluconazole treatment. (B) 72 hours after the fluconazole treatment. (C) 96 
hours after the fluconazole treatment. (D) 120 hours after the fluconazole treatment. NFpump 
cells were cultured in 7 different fluconazole concentrations: 0, 0.2, 0.4, 0.6, 0.8, 1 and 1.5 
µg/ml. In each sample, cell culture was started with 0.5 x 106 cells/ml, and every 12 hours, cell 
density was measured by Nexcelom, a small amount of cell culture based on the calculation 
was inoculated into fresh medium to start new culture with the same cell density, 0.5 x 106 
cells/ml. Cell growth rate was then calculated and plotted. PDR5::GFP expression was 
measured by flow cytometry every 24 hours. 
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So far, I identified the range of fluconazole concentrations to induce Pdr5 expression in 
NRpump and NFpump, but there was a gap in the histogram between fluconazole 1 µg/ml and 
1.5 µg/ml, especially in NFpump cells. I wanted to further narrow down the concentrations to 
characterize the fluconazole dose-response change by fluconazole. Therefore, another set of 
fluconazole concentrations (0, 0.8, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.7 and 2.0 µg/ml) was used to 
treat NRpump and NFpump cells. In the first 12 hours after treatment, NRpump cells in all the 
fluconazole concentrations expressed low level of Pdr5 and the expression was uniform, 
indicated by single peak in the histogram. Starting at 24 hours after treatment, NRpump cells in 
the fluconazole concentrations of 1 µg/ml and above showed slightly higher Pdr5 expression, 
and the cell number decreased compared to cells in the fluconazole concentrations of 0 and 0.8 
µg/ml, indicating decreased growth rate. With longer fluconazole treatment, more cells at the 
fluconazole concentrations of 1 µg/ml and above turned into high Pdr5 expressers. During this 
transition, cells showed bimodal expression of Pdr5. NRpump cells treated with a fluconazole 
concentration of 0.8 µg/ml showed low Pdr5 expression level at the beginning of this 
experiment, but a portion of cells started to turn into high Pdr5 expressers after 60 hours in the 
treatment, the process lasted until 324 hours after fluconazole addition. This result showed that 
a fluconazole concentration of 1 µg/ml was also able to elicit Pdr5 expression from NRpump 
gene circuit, but at a much slower pace compared to cells treated with higher fluconazole 
concentrations.  In this experiment, I noticed one very interesting phenomenon; cells treated 
with a fluconazole concentration of 1.1 µg/ml first turned from low expressers to high 
expressers, then they switched back to low expressers after 156 hours in the treatment. Then at 
252th hour after treatment, the low expressers started to switch to high expressers again until 
the whole population became completely high expresser at 348th hour in the treatment, then the 
cells stayed as high expressers until the end of experiment, which was 396 hours in the 
fluconazole environment.  
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Figure 5.9 NRpump histograms in the fluconazole concentrations of 0 – 2 µg/ml. 
(A) to (V) 12 hours after the fluconazole treatment to 396 hours after the treatment. Fluconazole 
concentrations used here were:  0, 0.8, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.7 and 2 µg/ml. In each 
sample, cell culture was started with 0.5 x 106 cells/ml, and every 12 hours, cell density was 
measured by Nexolum, a small amount of cell culture based on the calculation was inoculated 
into fresh medium to start new culture with the same cell density, 0.5 x 106 cells/ml. Cell growth 
rate was then calculated and plotted. PDR5::GFP expression was measured by flow cytometry 
every 24 hours. 
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Next, I wanted to see if NFpump cells would show the same pattern in the new set of 
fluconazole treatment as NR did. The data showed that it took longer for NFpump cells to 
reposed to fluconazole compared to NRpump (Figure 5.10), and this result matched well with 
previous fluconazole treatment result, in which NFpump was more resistant to fluconazole than 
NRpump naturally (Figure 5.3). With longer fluconazole treatment, NFpump cells showed the 
same pattern as NRpump did: NFpump cells treated with fluconazole concentration 1 µg/ml and 
above gradually became high Pdr5 expressers from low expressers. However, cells treated with 
a fluconazole concentration of 0.8 µg/ml only began to show high Pdr5 expressers by 396 hours 
after the treatment, this took much longer compared to NRpump cells, which confirmed that 
NFpump was naturally more resistant to fluconazole than NRpump cells because of its high 
basal expression. Similar to NRpump cells, I also noticed that NFpump cells cultured in certain 
fluconazole concentration also switch forth and back and NRpump cells did, but the fluconazole 
concentration that induced this switch was different from NRpump. NFpump cells treated with 
1.2 µg/ml switched from low Pdr5 expressers to high expressers with longer fluconazole 
treatment. Then the high expressers started to turn back to low expressers after 252 hours after 
the treatment, and the low expressers switched to high expressers again at 396th hour during 
fluconazole treatment. For NRpump and NFpump strains evolved in all these experiments 
above, frozen stocks were saved. 
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Figure 5.10 NFpump histograms in the fluconazole concentrations of 0 – 2 µg/ml. 
(A) to (V) 12 hours after treatment to 396 hours after treatment. 10 Fluconazole concentrations 
were used:  0, 0.8, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.7 and 2 µg/ml. In each sample, cell culture was 
started with 0.5 x 106 cells/ml, and every 12 hours, cell density was measured by Nexcelom, a 
small amount of cell culture based on the calculation was inoculated into fresh medium to start 
new culture with the same cell density, 0.5 x 106 cells/ml. Cell growth rate was then calculated 
and plotted. PDR5::GFP expression was measured by flow cytometry every 24 hours. 
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5.4 Conclusion and Discussion 
In this project, I have shown that Pdr5 was able to protect Saccharomyces cerevisiae 
cells from the fluconazole treatment up to a concentration of 10 µg/ml. Non-tetracycline family 
molecule induced NRpump, NFpump and PFpump treated with fluconazole all showed dramatic 
reduction of growth rate in the first 12 hours. However, NRpump and NFpump cells fully 
recovered their growth rate to the normal level after 48 to 60 hours in the presence 
offluconazole, while the growth rate of PFpump cells remained extremely low during the entire 
fluconazole treatment. This discovery suggested a possibility that NRpump and NFpump gene 
circuits were broken in the presence of fluconazole, so that TetR was not able to repress PDR5 
transcription even in the absence of tetracycline family inducers, which led to the expression of 
Pdr5 from the two synthetic gene circuits. In order to test this hypothesis, flow cytometry was 
used to monitor PDR5::GFP expression after fluconazole treatment. The result confirmed the 
correlation between growth rate and PDR5::GFP expression level. The reduced growth rate in 
the initial fluconazole treatment was associated with basal PDR5::GFP expression, while the 
increased PDR5::GFP expression was associated with the recovery of growth rate in NRpump 
and NFpump cells. The histograms of PDR5::GFP expression remained the same even after the 
fluconazole removal, supporting the hypothesis of gene circuits’ being broken in both NRpump 
and NFpump cases. These results suggested that the recovered growth rate was due to 
expression of Pdr5 from the gene circuits. Genetic mutations causing this most likely might 
contributed to the appearance of resistant cells. This needs further investigation by whole 
genome sequencing.  
During the process of growth rate slow-down and recovery, NRpump and NFpump cells 
treated with six different fluconazole concentrations behaved similarly. The results suggested 
that the fluconazole concentrations between 2 µg/ml and 10 µg/ml were not able to differentiate 
NRpump and NFpump. Therefore, the question arose whether fluconazole was able to elicit 
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different distribution of Pdr5 expression. In order to answer this question, lower sets of 
fluconazole concentrations were used to treat NRpump and NFpump cells. The results indicated 
that the fluconazole concentration of 0.8 µg/ml was the threshold for generating resistance by 
increased expression in both NRpump and NFpump cells. It’s also been noticed that the lower 
the fluconazole concentration was, the longer it took to elicit resistance in NRpump and 
NFpump cells; and the appearance of resistance was again confirmed to involve Pdr5 
expression from the gene circuits. However, at intermediate fluconazole concentration, Pdr5 
expression showed bimodality, which was not normal, because negative feedback loop has 
been proved to reduce gene expression noise, and NFpump showed unimodal distribution of 
Pdr5 expression when induced by doxycycline, no matter what concentration was used (Data 
shown in Chapter 3). This data suggested the existence of another subpopulation, which was 
resistance to fluconazole without Pdr5 expression from the gene circuit, or stochastic switching 
in a genetically homogenous population. 
In order to further confirm the bimodality of Pdr5 expression in both NRpump and 
NFpump cells, more fluconazole concentrations in between 1 µg/ml and 1.5 µg/ml were used to 
elicit NRpump and NFpump cells, and the experiment lasted much longer to observe the 
dynamics of Pdr5 expression in the fluconazole environment. In the experiment, both NRpump 
and NFpump cells were induced at 10 fluconazole concentrations ranging from 0 µg/ml to 2 
µg/ml for 396 hours. In the initial treatment, the growth rate of NRpump and PFpump cells 
slowed down with all the cells expressed low level of Pdr5 as expected. After 48 hours, both 
NRpump and NFpump cells started to recover their growth rate. During this process, a portion of 
cells became Pdr5 high expressers while others remained as low expressers. With longer 
treatment, an increasing percentage of cells became high expressers, until all the cells 
expressed a high level of Pdr5, and that was the time that NRpump and NFpump cells fully 
recovered their growth rate. However, at certain fluconazole concentration (1.1 µg/ml for 
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NRpump and 1.2 µg/ml for NFpump), a backward switch of Pdr5 expression showed up in both 
NRpump and NFpump cells. In other words, when all the cells became Pdr5 high expressers, a 
fraction of low Pdr5 expressers started to show up and increase, on the contrary, the 
percentage of high expressers shrank. This process lasted for around 100 hours and the low 
expressers eventually disappeared, then all of the cells became high expressers again. The 
sudden disappearance of low Pdr5 expressers at 396th hour after fluconazole treatment was 
suspicious, because the peak of low expressers had been increasing until the last time point 
before 396th hour. Unknown mechanisms must have occurred during this 12 hours time period. 
These results suggested several possibilities. First of all, there was no genetic mutation 
occurred during the entire fluconazole treatment, but two genetically identical subpopulations 
with different Pdr5 expression level existed, which contributed to the bimodality. The 
appearance of high expressers and recurrence of low expressers were due to stochastic 
switching. This is only possible when fluconazole induces the gene circuits’ expression. Second 
possibility was genetic mutations on the synthetic gene circuits. The appearance of high 
expressers was due to the breakdown of NRpump and NFpump gene circuits, meaning that 
TetR was not able to repress Pdr5 expression any more, which might be due to two potential 
mechanisms: the TetR sequence mutated so that it could not bind to the promoter of 
PDR5::GFP, and the mutation of TetO sequence, which was the binding sites of TetR. As a 
result, the expression of Pdr5 conferred cells resistance to fluconazole and had the higher 
growth rate than cells without gene circuit breakdown, which explained the show-up of high 
expressers. The recurrence of low expressers was probably due to other genetic mutations 
occurred that conferred cells resistance to fluconazole. Overall, the results were more likely due 
to the combination of the last two possibilities, genetic mutation on both gene circuits and other 
places on the genome occurred during fluconazole treatment.  
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5.5 Future direction 
Fluconazole was discovered to induce resistance in NRpump and NFpump cells in no 
tetracycline family molecule environment. Three major hypotheses were proposed to explain 
this result, stochastic switching, genetic mutation on the gene circuits and genetic mutation of 
other genes involved in cell membrane synthesis, which was the target of fluconazole 
resistance. The next step will be to test these hypotheses. First of all, stochastic switching 
theory will be tested. NRpump and NFpump cells treated with fluconazole concentrations that 
induced different distribution of Pdr5 expression will be used to culture in no fluconazole 
environment. If the histogram of Pdr5 expression remained the same after fluconazole removal, 
it proved that the emergence of Pdr5 high expressers was not a result of stochastic switching. 
However, if the percentage of high expressers decreased with the increase low expressers and 
eventually low expressers take over the population, then two possibilities exist. 1) stochastic 
switching; 2) low expressers took over the population because of their higher fitness compared 
to high expressers. Therefore, the next step will be to test if NRpump and NFpump gene circuits 
were broken. Expression of PDR5::GFP suggested the loss of function of TetR repression. Two 
possible events will contribute to this, mutation of TetR or mutation of TetO sites on the modified 
GAL1 promoter. Thus, TetR and modified GAL1 promoter on NRpump and NFpump gene 
circuits will be amplified by PCR and sequenced. The appearance of mutation on the 
sequencing results will suggest the breakdown of gene circuits, but confirmation experiments 
still need to be done. For example, replacing the wild type TetR or TetO sites with mutated ones 
to see if they are inducible by tetracycline family molecules. However, it is possible that no 
mutation will show up in the entire cell population or some cells in the population, for example, 
the NFpump low expresser subpopulation emerged after 276 hours in 1.2 µg/ml fluconazole. In 
that case, genes that will confer resistance to fluconazole will be tested. ERG2, ERG3, ERG4, 
ERG6 and ERG11, which are involved in the alteration of sterol biosynthesis will be tested 
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because fluconazole blocks the natural synthesis of ergosterol which is an important component 
in cell membrane. Expression of other ABC family members will be tested as well. Although the 
endogenous Pdr5 has been knocked out in NRpump and NFpump cells, mutations of other 
multidrug resistance pumps, such as PDR10, PDR11, etc., might be able to compensate for its 
function.  
Besides testing fluconazole resistance mechanisms in non-doxycycline induced 
NRpump and NFpump cells, the evolution dynamics of NRpump, NFpump and PFpump gene 
circuits in fluconazole was interesting and worth investigation as well. Study of their evaluation 
dynamics will help us better understand their natural selection process, and discover the 
evolution process of drug resistance, which might provide insight on our treatment of drug 
resistance. In order to better mimic natural systems and environment, fluctuating fluconazole 
concentrations will be used to treat these three gene circuits, because natural environment 
always keeps changing, a constant lasting environment rarely exists in nature. However, the 
evolution mechanisms discovered when the three gene circuits in constant fluconazole 
environment will lay the foundation for further study of evolution in fluctuating environment. 
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Chapter 6 Discussion and perspectives 
 
In this dissertation research, I studied the interaction between a protein pump, Pdr5, and 
three synthetic gene circuits that regulate it. I compared the dose-response behavior of 
NRpump, NFpump and PFpump gene circuits with that of their non-pump counterparts, NR, NF 
and PF. The results indicated that Pdr5 changed the dose-response behavior of the original 
gene circuits. The change came from two resource. One was the efflux pumping function of 
Pdr5, and the other was reduced TetR expression in the pump strains. The additional change 
that Pdr5 caused in PF gene circuit was largely reduced cellular memories in the two 
subpopulations. Then I studied the molecular evolution of the three pump gene circuits in 
constant fluconazole containing environment, the resulted suggested the breakdown of 
NRpump and NFpump supported by the fact that PDR5::GFP was expressed from these two 
gene circuits. However, PFpump did not show any sign of change of growth rate and dose-
response in 120 hours. 
This study was the first one to characterize the behavior of NR, NF and PF gene circuits 
controlling an active target gene that affects the upstream regulatory elements experimentally in 
Saccharomyces cerevasiae, although mathematical models simulated the dose-response of 
another pump under the control of interlinked negative feedback and positive feedback loops in 
E. coli before 123. The results of this study established the connection between experimental 
data and mathematical models, as my data was used to tune the stochastic simulations of pump 
gene circuits dose-response developed by my collaborator (Data not shown). The models he 
simulated matched well with experimental results, and it also provided insight to advance my 
research in the search of factors contributing to the change of dose-response in pump strains.  
In this search, I discovered that the tetR expression was reduced in all the pump strains, 
which contributed to the dose-response change by decreasing its repression on the transcription 
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of PDR5::GFP. As a result, reduced tetR expression increase pump strains’ sensitivity to the 
inducer, doxycycline. This increased sensitivity was not related to the efflux pumping function of 
Pdr5, supported by the evidence that pump strains with non-functional Pdr5 still showed the 
same level of sensitivity to doxycycline. In the search for potential causes of reduced TetR in 
pump strains, I narrowed them down to transcriptional level regulation, and the result was likely 
due to gene circuit’s construction for the pump strains. Because PDR5 was over 5kb nucleic 
acids long and was right preceding the promoter region of TetR, it is highly possible that the 
large PDR5 gene sequence negatively affected the downstream transcription of TetR. Although 
other possibilities still exist, such as epigenetic modification of PDR5, researchers studying 
PDR5 should pay more attention to the gene circuits’ construction to avoid potential problems.  
Another factor that contributed to the change of dose-response in the pump strains was 
the efflux pumping function of Pdr5. Besides, I also showed the exact difference it caused, such 
as the loss of linearity in NF. These results laid the foundation for further study on PDR5 under 
other genetic circuits and even the behaviors of other active target genes (other protein pumps) 
in different regulatory networks. For example, genetic toggle switches might need higher inducer 
concentration to complete the switch when they are controlling PDR5, the concave dose-
response curve might become less concave, or even linear. This might create a gradual switch, 
which can be used to fine tune desired output. Oscillator involves PDR5 might lose oscillation 
since the key for oscillator requires delayed negative feedback 71, the addition of another PDR5 
induce negative feedback might destroy oscillation. However, oscillation might appear when 
PDR5 is under control of a positive feedback loop and worth trying in the future since this 
potential genetic oscillator is simpler than other existing ones.  
Besides insight to other gene circuits, this study has numerous applications as well. 
Since PDR5 is involved in a number of biological processes, and has a variety of substrates, we 
are able to deliver precise control over them using our system. Although Pdr5 changed the 
linearity in NF, but the noise reduction nature of negative feedback still makes NFpump more 
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precise than NRpump in controlling target gene expression, and the subsequent exclusion of 
target gene substrates. Recent research discovered that protein pump helped to increase 
production of biofuel in E. coli by exporting biofuel molecules outside the bacteria to reduce 
toxicity and increase growth rate of host microorganisms 123. We can do better by using our 
system to regulate the intracellular biofuel molecules precisely so that the cells growth rate and 
productivity will stay at the optimal level. Even more, we can combine our system with a 
biosensor system to detect certain molecules and respond automatically. For example, a 
recently engineered biosensor in yeast cells is able to detect steroids hormones 147, we can 
build an automatic system for production of steroids by adding biosensor to our system to 
deliver multilevel regulation. Different concentration of intracellular steroids will automatically 
results in different Pdr5 expression to maintain the production at the optimal level. Besides 
regulation of biomaterial production, our PDR5 system can be used to advance basic research 
as well. A group of Pdr proteins in Saccharomyces cerevasiae have been shown to play a major 
role in the aging 148, our NFpump gene circuit can be used to study the dynamics and effect of 
ageing process more precisely. Besides, our system can facilitate research on multidrug 
resistance (MDR) pump mediated drug resistance. Earlier studies discovered that transcriptional 
noise led to phenotypic consequences 25, 34, 39, 40, 46, one cause for drug resistance is MDR gene 
expression noise. Since NF gene circuit reduces transcriptional noise, using NF controlling MDR 
pump is able to study drug resistance appearance and treatment more specifically.   
This research also identified the change of growth rate and cellular memory caused by 
Pdr5 in PF strain. Although exceptions exist, positive feedback loop is considered to produce 
bimodal distribution 1, 79, 149-152, which means the existence of two stable steady states in terms 
of expression, ‘ON’ and ‘OFF’. In order to describe the transition between the two stable states, 
cellular memory was used, which was defined as the average time of an individual cell stays in 
one stable steady state. The results showed that Pdr5 reduced the cellular memory of high 
expresser significantly. Although it still needs further confirmation, the reduction was highly likely 
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due to the efflux pumping function of Pdr5. This data suggested a possibility to change cellular 
memory by introducing negative feedback loops. By doing so, another interesting question rose, 
if the strength of negative feedback loop affects the cellular memory as well. It’s been know that 
positive feedback coupled with delayed negative feedback produces oscillator 1, 2, 21, 71, 131, it will 
be interesting to see the correlation between the strength of negative feedback and the 
frequency of the oscillator.  
Finally, this dissertation also studied the evolution of synthetic gene circuits, and 
discovered that the gene circuits involving TetR repression was likely to break down in 
fluconazole environment. Besides the insight it provided to study of evolutionary course of 
regulatory networks in biological systems, it also showed the weakness of TetR based 
regulatory systems when facing adverse environment containing drugs. Further improvement of 
drug resistant TetR systems should be done, concerning the wide usage of Tet systems in the 
study of drug resistance in biomedical sciences. 
Although the chances are low, there are a few things in the projects that might lead to 
alternative conclusions. First of all, the original NR and NF gene circuits used yEGFP as 
reporter, while all the pump stains used GFP. The fluorescence intensity of GFP is one tenth of 
that of yEGFP. Therefore, all the data has to be normalized for comparison of dose-responses 
between non-pump and pump strains. In this case, we can not compare the actual fluorescence 
intensity value, which indicates the actual expression level of ZeoR and Pdr5. It is possible that 
the expression of these two target genes is different. However, the normalization works for my 
study because here we only compare the difference between non-pump and pump strains.  
The second experiment that might need improvement is the dose-response experiment 
for NR strain. NRpump and NRpump mutant strains were all induced by doxycycline 
concentration up to 15 μg/ml, but NR was induced up to 10 μg/ml. The reason I only used up to 
10 μg/ml was that NR dose-response experiment was done first, and I found that the histograms 
of NR did not change after doxycycline concentration reached 7 μg/ml, indicating that the 
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expression of target gene reached saturation in the cell population. However, when I did the 
dose-response experiment for NRpump, I found that they saturated at higher doxycycline 
concentration compared to NR. Therefore, I used higher doxycycline concentration for NRpump. 
However, this might have introduced an uncertainty that affects the conclusion of my study. 
Because all the data was normalized to the fluorescence intensity value at the highest 
doxycycline concentrations for all the strains, and the fluorescence intensity values are different 
at doxycycline concentration 10 μg/ml and 15 μg/ml for NRpump. Therefore, if the data is 
normalized to the fluorescence intensity value at doxycycline concentration 10 μg/ml as it was 
done for NR, it might cause the increase of the fluorescence intensity mean at all the 
doxycycline concentrations. This might result in a closer gap between NR and NRpump mean 
dose-response at doxycycline concentration 7 μg/ml. Right now, the ANOVA test confirmed 
significant difference between NR and NRpump mean at doxycycline concentration 7 μg/ml. 
However, the difference is not guaranteed to be significant if the data is normalized to 
fluorescence intensity value at doxycycline concentration at 10 μg/ml.  Therefore, in order to 
prove that, higher doxycycline concentration should be used to induce target gene expression 
until no more increase of fluorescence intensity is observed from doxycycline concentration 
increase.  
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